hg_154330.1

Basic information about the TSS

---

TSS ID: hg_154330.1 Species: human Chr: chr16		Start: 57245336 End: 57245364 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000562023.5 Distance: 0 GeneID: 23568 HGNC/MGI_ID: HGNC:17146 UniProt_ID: H3BU49

Gene_name: ADP ribosylation factor like GTPase 2 binding protein Gene_symbol: ARL2BP Gene_synonyms: BART BART1 Gene_source: HGNC:17146

TATA-Box annotation

---

Distance to TSS:	91
Nearest PromoterID:	NM_012106
Entrez ID:	23568
Nearest Unigene:	Hs.632873
Nearest Refseq:	NM_012106
Nearest Ensembl:	ENSG00000102931
Gene Name:	ADP ribosylation factor like GTPase 2 binding protein
Gene Alias:	BART|BART1|RP66
Gene Description:	ADP ribosylation factor like GTPase 2 binding protein
Gene Type:	protein-coding
CpG%:	0.1
GC%:	0.696517
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ARL2BP p2@ARL2BP p3@ARL2BP p4@ARL2BP p5@ARL2BP p6@ARL2BP p7@ARL2BP
Sample		p1@ARL2BP	p2@ARL2BP	p3@ARL2BP	p4@ARL2BP	p5@ARL2BP	p6@ARL2BP	p7@ARL2BP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	10.13	16.95	2.53	1.75	1.17	0.19	1.95
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	11.33	19.42	4.45	1.21	0.20	0.00	1.21
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	10.80	20.64	3.47	1.54	0.58	0.39	2.51
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	9.36	16.01	2.08	1.46	1.04	0.62	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	12.60	18.90	1.57	2.70	0.45	0.67	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	9.11	18.61	1.55	2.13	0.78	0.19	2.13
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	20.48	28.76	5.23	5.66	1.53	1.31	3.05
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	20.35	23.25	4.12	1.21	0.48	0.73	2.42
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	19.02	28.21	4.92	3.63	1.07	1.07	2.35
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.23	25.50	4.64	2.32	0.58	2.32	3.48
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	10.51	16.17	2.43	3.64	0.40	2.43	3.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	14.23	15.86	0.41	1.22	0.00	1.63	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	14.83	3.87	0.81	6.61	3.06	1.61	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.83	4.21	0.75	6.47	3.46	1.80	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	9.22	4.39	0.66	5.71	4.61	1.98	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	10.56	4.28	1.01	5.78	3.52	1.26	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.41	3.71	0.87	5.02	3.06	1.75	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	14.76	2.95	0.84	2.95	3.37	1.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	11.73	3.73	0.00	2.67	3.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	11.88	4.81	0.90	5.87	3.31	3.31	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	12.83	4.28	1.20	6.55	2.41	1.20	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	16.57	5.70	1.38	5.01	2.93	1.90	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.57	4.78	1.29	6.46	2.20	1.68	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	11.65	3.88	0.97	3.40	2.67	1.94	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	13.42	2.32	1.29	8.51	2.32	3.61	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	10.76	2.53	1.27	5.70	2.53	1.90	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	9.34	2.75	1.10	8.24	1.65	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	15.56	4.48	0.94	5.19	2.59	2.36	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	10.98	8.08	0.65	4.04	2.75	1.45	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	9.23	4.34	0.90	7.78	3.80	3.62	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	9.84	6.07	1.05	6.28	2.51	1.05	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	10.75	6.64	1.76	4.30	2.74	2.93	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.76	9.29	0.84	5.70	2.53	1.90	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	12.54	8.08	1.32	7.26	6.27	2.31	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	9.72	3.74	1.87	6.54	4.11	2.06	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.88	3.64	0.96	4.79	3.26	3.83	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	14.72	4.70	1.02	8.99	2.04	4.29	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	10.48	5.44	1.61	4.84	2.42	1.41	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	11.07	3.78	1.89	4.05	4.05	2.97	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.76	5.52	1.68	5.04	4.56	4.80	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	15.06	5.65	1.65	7.53	2.82	0.94	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	14.49	6.00	1.02	8.93	2.34	2.49	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	15.40	8.65	1.48	8.44	1.90	3.59	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	13.99	6.12	1.05	8.74	3.15	2.27	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	13.85	7.03	1.81	6.02	4.22	3.21	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	15.12	6.75	2.09	7.91	6.05	3.26	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	12.24	7.68	1.92	10.32	2.40	1.68	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.29	7.45	1.49	7.75	2.38	2.38	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.06	10.29	1.68	11.01	3.83	4.79	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	19.21	8.29	2.02	10.31	3.64	5.86	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	21.93	8.40	1.64	12.30	5.53	3.28	1.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	29.13	8.67	2.67	16.23	4.23	6.89	2.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	27.98	13.99	13.99	13.99	27.98	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	23.78	7.10	2.48	11.36	5.32	3.19	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.86	8.28	1.99	8.62	5.30	2.65	1.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	29.36	8.39	2.52	7.55	20.13	14.26	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	31.23	10.10	3.21	13.78	4.13	7.35	2.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	30.47	10.37	0.32	12.96	2.59	3.24	1.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	21.20	10.60	0.64	13.81	1.61	5.46	3.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	37.09	16.03	2.20	17.92	8.17	9.43	2.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	26.79	5.64	1.41	11.99	2.82	5.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	21.87	4.49	1.12	12.90	2.80	2.80	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	39.81	14.33	1.59	21.50	11.15	16.72	4.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	34.66	12.91	2.04	14.61	5.78	6.46	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	29.89	13.97	1.30	16.25	2.60	2.60	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	24.49	13.49	0.35	13.13	3.55	1.77	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	94.77	15.79	0.00	7.90	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	20.96	7.31	0.98	10.73	2.93	1.46	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	37.69	10.41	1.98	11.90	1.98	1.98	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	29.09	9.85	1.88	15.48	1.41	1.41	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	33.78	10.93	0.99	14.90	1.99	2.98	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	30.93	10.21	0.93	14.23	4.95	1.86	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	28.74	10.09	2.45	11.62	2.14	2.14	0.92
Adipocyte - breast, donor1	11376-118A8	27.40	9.19	4.91	11.88	6.18	5.07	1.43
Adipocyte - breast, donor2	11327-117E4	21.34	11.39	3.69	11.55	4.33	4.81	1.76
Adipocyte - omental, donor1	11473-119C6	20.48	11.32	6.11	8.91	2.93	3.31	1.40
Adipocyte - omental, donor2	11474-119C7	15.70	9.72	2.99	13.45	3.74	4.48	3.74
Adipocyte - omental, donor3	11475-119C8	10.72	10.05	2.01	7.03	1.34	2.68	1.00
Adipocyte - perirenal, donor1	11476-119C9	20.42	7.66	4.47	10.21	2.55	5.74	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	14.29	7.70	1.10	5.50	3.30	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	29.36	8.58	0.90	10.84	5.42	4.52	1.81
Adipocyte - subcutaneous, donor3	11408-118E4	19.29	11.47	5.39	6.60	5.21	2.09	1.74
Adipocyte differentiation, day04, donor1	13019-139D4	31.68	15.65	3.52	15.25	3.91	1.96	0.98
Adipocyte differentiation, day04, donor2	13022-139D7	19.56	9.01	1.03	7.98	0.51	1.80	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	22.58	7.81	2.79	13.66	2.79	3.90	0.84
Adipocyte differentiation, day04, donor4	13028-139E4	30.57	7.64	2.94	8.23	2.35	2.35	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	31.05	21.56	3.14	15.44	4.42	7.24	2.73
Adipocyte differentiation, day08, donor2	13023-139D8	23.24	9.68	0.65	13.88	2.26	2.90	1.61
Adipocyte differentiation, day08, donor3	13026-139E2	16.53	8.53	3.20	9.06	1.60	2.67	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	26.15	11.69	1.67	10.57	1.67	4.45	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	21.63	14.56	0.83	17.05	3.74	5.41	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	22.35	12.06	1.00	7.53	5.27	4.02	1.76
Adipocyte differentiation, day12, donor3	13027-139E3	18.00	14.40	1.96	11.78	2.29	4.25	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	18.27	10.35	1.22	9.74	2.44	5.18	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	17.24	13.70	3.09	3.31	1.55	3.09	1.33
Alveolar Epithelial Cells, donor2	11590-120G6	4.66	5.02	0.72	1.08	1.08	0.36	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	2.40	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	13.49	30.22	10.07	1.80	1.08	1.62	2.16
Amniotic Epithelial Cells, donor2	11613-122A2	6.69	16.73	6.69	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	13.35	15.41	7.19	1.44	0.82	0.41	1.23
Anulus Pulposus Cell, donor1	11248-116E6	32.61	12.13	3.66	11.10	5.26	3.09	2.17
Anulus Pulposus Cell, donor2	11463-119B5	20.57	10.53	2.45	10.78	4.41	4.16	1.22
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	25.16	9.88	6.29	5.84	1.80	2.70	1.35
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	27.35	18.23	3.47	6.08	1.74	1.74	2.60
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	21.40	12.84	4.28	8.56	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	27.50	8.07	4.78	8.37	2.39	1.49	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	24.03	16.44	2.53	7.59	3.79	3.79	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	20.46	7.26	3.30	11.22	0.66	0.00	3.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	26.32	13.97	2.60	7.15	1.95	0.32	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	11.65	3.40	7.77	2.91	0.97	3.40
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.85	7.13	4.75	7.72	2.38	0.59	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	21.09	16.20	1.88	4.90	2.64	3.01	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	24.67	13.79	2.18	5.81	2.18	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	8.78	3.76	8.78	2.51	1.25	2.51
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	24.22	13.01	3.95	9.23	0.82	1.15	2.47
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	5.46	6.82	4.09	4.09	6.82	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	33.63	13.87	4.98	8.14	1.06	0.75	2.87
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	18.22	11.79	4.29	10.72	2.68	0.54	1.61
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	27.02	13.23	3.78	12.85	1.13	2.27	1.70
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	26.19	9.62	4.28	8.29	1.87	2.14	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	23.41	5.85	0.98	14.63	1.95	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	24.05	13.10	3.48	8.79	2.32	2.49	1.82
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	21.61	3.60	4.80	7.20	0.00	1.20	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	21.24	7.08	7.08	7.08	0.00	0.00	3.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	25.21	12.69	3.43	7.72	0.69	1.54	1.89
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	16.78	20.97	0.00	8.39	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	24.76	13.11	3.40	8.74	3.40	0.97	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	26.56	17.08	4.93	12.14	1.14	2.28	2.28
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	21.80	6.06	3.63	2.42	2.42	4.85	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	31.35	17.67	3.99	9.12	3.42	3.42	5.13
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	23.94	12.83	4.70	9.41	1.28	1.50	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	18.84	11.36	3.10	8.52	1.55	1.29	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	20.65	9.38	2.35	6.57	0.94	0.47	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	26.05	10.29	2.89	6.75	1.61	1.61	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.98	11.42	2.85	5.71	1.43	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	23.40	11.11	2.92	7.60	2.92	1.75	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	20.47	11.74	3.91	11.14	0.30	1.20	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	22.57	3.56	3.56	8.32	2.38	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	24.92	11.19	4.07	6.10	3.05	1.53	2.54
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	21.39	9.17	2.04	9.93	3.06	1.53	2.04
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	17.79	10.17	0.64	8.90	0.00	1.27	2.54
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	23.73	11.65	4.32	7.34	1.29	2.59	2.16
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	23.92	12.07	4.02	8.89	1.48	2.12	1.69
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	23.20	9.86	1.45	8.12	2.03	1.16	2.61
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	9.45	4.72	9.45	1.89	2.83	3.78
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	23.90	11.53	4.92	9.49	1.19	0.68	2.88
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	20.85	4.63	2.32	13.90	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	25.35	16.90	8.45	16.90	2.11	4.23	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	24.66	17.37	2.57	8.58	1.50	2.57	2.14
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	21.66	8.42	2.41	6.62	3.61	0.60	2.41
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	19.68	16.77	0.73	12.39	1.46	1.46	2.92
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	23.45	17.47	3.68	11.95	3.22	1.61	2.07
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	17.85	2.55	7.65	0.00	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.39	18.56	5.08	13.22	1.53	1.53	3.81
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	24.77	13.63	2.89	8.26	1.45	2.68	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	24.79	13.16	3.37	7.96	1.53	0.61	2.45
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	22.94	20.55	3.35	5.74	2.39	0.96	2.87
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	30.16	16.41	3.55	11.31	3.33	2.88	1.55
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	10.68	4.58	1.53	1.53	1.53	4.58
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	27.14	13.85	3.88	7.75	1.66	1.66	2.22
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	23.04	18.27	3.97	7.41	1.06	2.91	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	22.17	13.81	1.82	9.09	0.73	1.82	1.82
Astrocyte - cerebellum, donor1	11500-119F6	26.65	26.16	6.26	5.28	0.98	1.23	2.82
Astrocyte - cerebellum, donor2	11580-120F5	17.46	13.18	3.59	5.48	0.34	1.03	1.71
Astrocyte - cerebellum, donor3	11661-122F5	13.21	14.68	6.29	5.03	0.63	1.47	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	34.51	32.77	10.11	8.37	1.39	2.44	2.09
Astrocyte - cerebral cortex, donor2	11316-117D2	28.47	22.00	7.28	8.90	2.10	2.26	1.46
Astrocyte - cerebral cortex, donor3	11392-118C6	25.80	27.30	11.78	5.22	1.64	1.04	2.39
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	21.45	12.62	4.24	1.15	0.80	0.34	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.43	13.78	4.38	2.00	0.63	0.38	2.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	21.51	13.20	4.10	2.62	0.46	0.34	1.93
Basophils, donor1	12241-129G9	13.60	10.46	7.58	1.83	0.26	0.26	0.78
Basophils, donor2	12242-129H1	12.63	18.76	18.04	2.16	1.08	0.72	1.44
Basophils, donor3	12243-129H2	16.76	8.82	6.47	3.53	0.73	1.62	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	5.17	16.39	10.13	0.22	0.65	0.22	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	3.66	5.49	1.37	0.00	0.91	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	14.35	0.00	0.00	14.35	0.00	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	10.67	18.20	1.26	0.63	0.63	0.63	1.26
Bronchial Epithelial Cell, donor5	11457-119A8	12.68	14.35	2.91	1.87	0.62	0.62	1.87
Bronchial Epithelial Cell, donor6	11461-119B3	11.28	21.42	4.84	2.30	1.38	0.92	0.46
Bronchial Epithelial Cell, donor7	11769-123I5	5.94	18.17	8.28	1.44	1.08	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	15.87	27.10	12.68	1.03	0.52	0.10	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	20.96	22.82	14.21	2.33	0.47	0.47	1.40
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	15.35	15.67	22.70	1.28	0.00	0.00	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	16.91	9.58	5.07	4.51	2.82	0.56	1.13
CD14+ Monocytes, donor2	11305-117B9	14.11	4.27	5.38	3.53	0.74	0.74	0.37
CD14+ Monocytes, donor3	11381-118B4	13.61	6.37	7.90	5.71	1.10	0.88	0.44
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	39.63	8.49	1.70	10.76	0.57	1.42	1.42
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	35.25	10.61	5.69	8.72	1.52	0.76	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	48.65	9.20	3.62	10.85	0.99	1.64	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	13.73	5.20	1.16	5.64	3.18	1.88	1.01
CD14+ monocytes - mock treated, donor2	11873-125C1	6.64	2.72	1.51	2.72	1.81	2.41	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	15.16	6.16	0.24	6.40	1.66	2.37	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.20	4.52	0.84	1.67	1.51	1.17	0.67
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	4.69	4.69	0.83	2.48	0.83	0.83	0.55
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	7.19	3.97	2.48	3.72	0.00	1.98	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	4.31	2.15	0.78	1.76	0.39	0.59	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.88	1.07	1.25	2.14	0.71	1.25	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	10.88	2.83	0.87	1.96	0.00	1.74	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	5.38	2.34	0.70	0.94	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	6.34	3.17	0.53	3.70	1.06	1.58	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	1.11	3.33	2.22	1.11	0.00	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	9.52	3.57	1.49	2.23	1.64	1.19	0.89
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.99	3.59	0.60	1.40	1.00	1.40	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.24	6.87	1.25	2.29	2.29	1.67	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	6.41	3.20	0.46	1.37	0.92	0.46	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.52	2.49	1.81	2.71	0.68	0.90	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	2.62	0.44	1.75	0.87	0.87	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	3.50	0.81	2.15	1.08	2.69	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.37	4.54	0.70	1.92	1.57	1.40	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	8.00	3.37	0.84	3.79	0.84	1.26	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.94	3.49	0.92	1.10	0.73	1.10	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.23	2.11	1.06	1.41	0.00	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.26	2.19	0.44	0.44	0.00	1.75	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	2.27	0.70	0.70	0.87	0.52	0.35
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.58	1.86	0.74	2.23	1.12	0.74	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.13	2.37	1.51	2.80	0.86	0.65	0.43
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	4.91	0.41	1.23	2.46	0.82	1.23	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.40	2.32	0.23	0.93	0.00	0.46	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.26	5.10	1.16	1.16	0.46	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	24.41	6.10	5.67	5.01	2.40	1.74	0.44
CD14+CD16+ Monocytes, donor2	11801-124D1	20.10	7.39	3.70	3.46	3.23	1.62	0.46
CD14+CD16+ Monocytes, donor3	11912-125G4	24.69	7.15	3.90	6.72	1.95	1.73	0.87
CD14+CD16- Monocytes, donor1	11788-124B6	38.62	9.65	4.67	8.41	2.80	1.56	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	29.17	8.91	1.75	6.46	1.22	0.87	1.40
CD14+CD16- Monocytes, donor3	11910-125G2	33.89	9.59	3.79	7.14	2.01	1.78	2.45
CD14-CD16+ Monocytes, donor1	11790-124B8	14.80	11.23	6.63	5.61	3.06	1.79	1.02
CD14-CD16+ Monocytes, donor2	11800-124C9	20.64	8.56	9.00	6.15	2.85	2.85	1.10
CD14-CD16+ Monocytes, donor3	11911-125G3	32.85	11.16	8.00	5.90	2.53	1.47	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	26.42	20.32	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	5.42	31.19	27.12	2.71	0.68	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	3.11	22.78	25.89	0.00	1.04	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	9.59	22.92	22.39	0.00	0.00	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	3.22	32.70	33.77	0.54	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	5.62	28.78	35.10	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	4.71	21.18	25.88	0.78	0.78	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	3.95	21.09	36.91	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	3.29	13.15	19.73	0.82	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	5.80	13.78	13.06	0.73	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	1.01	14.64	15.14	0.50	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	6.87	36.77	27.07	1.21	0.40	0.81	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	4.79	27.96	23.17	1.20	0.80	0.00	2.00
CD34+ Progenitors, donor1	11545-120B6	5.02	17.07	12.05	0.00	0.00	0.00	2.01
CD34+ Progenitors, donor2	11625-122B5	7.30	17.42	11.24	1.12	1.12	0.00	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	18.79	27.05	13.90	1.88	0.38	0.00	2.25
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	17.81	24.35	16.69	2.25	0.68	0.00	0.90
CD4+ T Cells, donor1	11225-116C1	0.36	22.14	57.13	0.00	0.36	0.36	0.36
CD4+ T Cells, donor2	11306-117C1	0.61	18.37	39.80	0.61	1.84	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	1.22	14.33	39.95	0.61	0.61	0.00	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	1.28	18.38	19.40	0.77	0.51	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	1.12	21.34	17.07	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	1.44	17.25	22.71	0.00	0.29	0.00	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.47	16.12	33.66	0.00	0.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	7.73	27.39	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	6.59	23.07	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	4.34	21.68	23.41	0.58	0.72	0.14	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	2.20	13.73	15.76	0.51	0.17	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	3.22	15.64	17.09	0.32	0.48	0.16	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	15.24	29.14	0.00	0.45	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	0.35	18.87	29.70	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	0.00	14.08	26.40	0.00	0.44	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	2.11	26.56	27.41	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	5.19	21.40	21.19	0.21	1.25	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	8.02	21.05	21.38	1.34	1.67	0.33	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.54	23.93	51.94	0.27	0.00	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	26.80	63.78	1.07	0.54	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	1.79	17.93	43.04	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	26.89	30.97	0.37	0.74	0.00	0.56
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	3.47	21.88	26.43	0.00	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	3.15	23.54	27.53	0.21	0.63	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.51	20.22	42.98	0.00	1.01	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.43	17.33	41.59	0.43	0.43	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.00	16.56	35.74	0.87	1.74	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	0.99	35.63	53.94	0.99	1.48	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	1.85	27.70	40.62	0.00	0.92	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	2.79	29.31	40.48	1.40	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	4.43	33.23	39.32	0.83	1.11	0.00	0.28
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	2.45	40.49	38.77	0.74	0.25	0.00	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	1.54	30.80	35.42	1.54	1.54	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	3.22	27.58	44.41	0.72	0.00	0.00	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	4.15	44.32	58.17	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1.31	20.63	43.87	0.98	1.31	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	1.13	15.77	30.41	0.38	1.50	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	1.77	21.21	38.38	0.00	1.26	0.00	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	28.44	15.83	2.75	10.09	2.06	1.38	1.38
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	30.67	11.98	2.16	7.19	0.96	1.20	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	31.74	13.41	2.46	6.29	1.92	1.92	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	32.42	16.21	2.10	3.90	3.60	3.90	2.10
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	29.28	14.40	2.64	8.40	2.16	2.64	0.96
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	31.83	13.42	2.96	8.64	0.68	0.68	1.36
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	29.33	11.95	1.30	8.26	0.65	1.30	1.96
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	26.32	11.05	2.90	7.11	0.53	1.84	1.84
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	28.85	11.02	1.88	6.80	0.70	0.47	1.64
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.17	11.17	4.23	5.13	0.00	1.51	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	29.34	13.36	1.74	5.52	0.58	0.58	2.03
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	29.31	11.99	2.66	7.19	0.80	0.80	2.66
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	16.20	13.13	1.75	6.57	0.88	3.06	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	23.68	14.12	1.82	8.65	0.91	3.19	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	21.63	12.68	0.75	5.22	2.24	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	28.81	14.41	3.24	7.56	2.16	1.44	3.60
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.53	13.81	2.30	7.48	0.86	2.01	2.30
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	33.00	12.49	1.89	7.78	1.18	1.18	3.06
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	30.42	18.38	2.54	7.92	1.90	1.90	2.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	31.99	14.76	2.15	6.77	1.54	2.46	1.85
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	26.29	12.82	3.21	6.09	0.96	1.28	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	21.04	9.94	1.53	8.41	1.53	0.38	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	18.92	15.76	1.97	5.91	0.39	1.97	2.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	14.37	12.86	1.51	3.78	3.03	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	28.91	16.06	0.80	2.41	1.61	0.80	4.82
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	32.87	22.38	2.10	3.50	2.10	1.40	1.40
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	22.04	5.01	9.02	1.00	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	12.79	7.31	3.66	3.66	3.66	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	11.86	13.83	1.98	2.96	1.48	1.98	1.98
Cardiac Myocyte, donor3	11686-122I3	24.31	16.31	6.63	7.16	2.00	2.95	1.37
Chondrocyte - de diff, donor1	11261-116G1	30.51	11.79	2.77	18.72	13.52	17.33	2.43
Chondrocyte - de diff, donor2	11338-117F6	28.07	15.99	1.78	13.86	5.33	2.84	2.49
Chondrocyte - de diff, donor3	11410-118E6	27.31	13.43	3.41	18.77	9.10	6.03	2.05
Chondrocyte - re diff, donor2	11339-117F7	14.32	4.48	1.79	6.27	10.74	8.95	2.69
Chondrocyte - re diff, donor3	11411-118E7	26.29	10.92	3.24	13.75	8.49	4.45	2.43
Ciliary Epithelial Cells, donor1	11242-116D9	31.67	22.26	10.10	3.33	1.03	0.80	2.30
Ciliary Epithelial Cells, donor2	11323-117D9	22.66	13.89	5.77	5.99	0.86	1.07	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	24.96	14.07	6.90	6.02	1.33	0.80	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	49.89	21.82	16.60	8.99	7.70	4.59	4.95
Corneal Epithelial Cells, donor1	11526-119I5	4.17	19.10	9.88	0.66	0.66	0.00	0.88
Corneal Epithelial Cells, donor2	11606-120I4	3.41	20.48	5.69	0.00	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	5.37	17.13	9.46	1.02	0.00	0.00	0.26
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	33.02	10.40	3.30	5.45	0.99	0.50	1.16
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	35.01	12.30	3.15	3.47	1.26	0.63	1.89
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	13.80	6.90	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	24.51	5.94	2.48	4.54	0.76	0.65	0.76
Dendritic Cells - plasmacytoid, donor1	11228-116C4	2.05	3.76	21.52	0.68	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	3.26	5.22	22.85	1.31	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	0.00	3.87	19.84	0.48	0.00	0.00	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	37.52	25.35	5.17	12.01	1.67	3.34	2.17
Endothelial Cells - Aortic, donor1	11263-116G3	25.23	18.78	2.35	14.08	1.76	2.93	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	37.33	28.56	4.81	15.27	1.70	1.70	2.26
Endothelial Cells - Aortic, donor3	11412-118E8	26.34	21.23	4.33	10.62	1.57	2.75	1.97
Endothelial Cells - Artery, donor1	11264-116G4	17.16	15.13	1.75	9.60	2.33	4.07	1.75
Endothelial Cells - Artery, donor2	11341-117F9	27.06	19.53	2.59	9.65	1.41	3.06	1.18
Endothelial Cells - Artery, donor3	11413-118E9	29.28	17.53	4.03	10.34	1.75	3.33	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	31.70	22.61	6.43	13.96	2.44	1.99	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	36.82	25.86	6.39	12.47	2.13	2.13	2.43
Endothelial Cells - Lymphatic, donor3	11393-118C7	43.13	29.88	4.79	11.56	2.54	3.66	1.97
Endothelial Cells - Microvascular, donor1	11265-116G5	22.88	24.96	2.38	10.70	1.78	2.67	2.38
Endothelial Cells - Microvascular, donor2	11342-117G1	36.45	20.83	3.64	10.41	0.52	1.56	3.12
Endothelial Cells - Microvascular, donor3	11414-118F1	23.82	19.28	2.41	9.36	1.84	2.13	1.84
Endothelial Cells - Thoracic, donor1	11266-116G6	31.61	34.41	2.80	22.41	2.40	6.80	1.60
Endothelial Cells - Thoracic, donor2	11343-117G2	23.06	13.10	2.62	6.81	0.52	1.05	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	51.69	36.90	11.18	17.77	3.98	3.23	5.09
Endothelial Cells - Umbilical vein, donor2	11324-117E1	30.20	21.73	5.21	9.34	1.96	2.61	3.04
Endothelial Cells - Umbilical vein, donor3	11400-118D5	34.81	22.47	4.76	13.56	2.08	1.83	3.05
Endothelial Cells - Vein, donor1	11267-116G7	22.75	22.75	4.55	7.96	1.14	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	29.34	18.86	2.79	11.18	4.19	2.10	1.40
Endothelial Cells - Vein, donor3	11416-118F3	30.62	21.04	3.77	14.92	2.20	3.93	2.67
Eosinophils, donor1	12244-129H3	0.00	121.98	30.49	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	14.85	13.20	4.95	4.95	0.00	0.00	3.30
Eosinophils, donor3	12246-129H5	3.57	10.70	10.70	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	5.86	12.22	6.11	1.47	0.73	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	20.80	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	32.54	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	24.63	11.90	4.11	10.26	4.93	2.46	2.46
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	24.63	9.96	2.08	13.91	4.93	4.82	3.07
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	27.30	12.46	3.68	18.09	10.29	4.55	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	26.56	12.25	3.76	14.19	4.97	5.09	2.06
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	10.92	8.87	1.77	7.23	1.91	4.50	2.05
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.52	11.50	3.16	9.18	4.11	3.90	2.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	4.48	4.74	0.26	5.01	7.11	3.95	0.53
Fibroblast - Aortic Adventitial, donor3	11401-118D6	21.26	13.29	5.32	9.97	7.64	6.98	1.99
Fibroblast - Cardiac, donor1	11268-116G8	20.87	12.25	2.27	9.07	2.72	2.72	2.27
Fibroblast - Cardiac, donor2	11345-117G4	29.56	7.58	0.76	9.85	0.76	2.27	5.31
Fibroblast - Cardiac, donor3	11417-118F4	12.62	7.41	2.05	5.84	0.79	0.79	1.58
Fibroblast - Cardiac, donor4	11452-119A3	31.83	10.61	4.85	7.27	2.42	6.67	3.03
Fibroblast - Cardiac, donor5	11456-119A7	21.45	16.88	2.03	10.03	1.90	3.17	1.52
Fibroblast - Cardiac, donor6	11460-119B2	17.13	12.58	1.82	9.55	1.67	3.34	1.21
Fibroblast - Choroid Plexus, donor1	11492-119E7	34.70	28.41	8.31	10.72	2.01	1.88	3.35
Fibroblast - Choroid Plexus, donor2	11572-120E6	18.98	10.79	5.61	5.18	2.16	1.29	1.73
Fibroblast - Choroid Plexus, donor3	11653-122E6	21.97	13.18	1.46	7.32	4.39	0.00	2.93
Fibroblast - Conjunctival, donor1	11531-120A1	15.91	15.91	5.77	5.30	1.15	1.15	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	27.48	15.60	11.70	14.93	8.99	3.39	1.87
Fibroblast - Dermal, donor1	11269-116G9	26.06	9.16	1.41	9.86	2.11	2.58	2.11
Fibroblast - Dermal, donor2	11346-117G5	30.66	13.68	4.25	16.98	1.42	2.36	4.25
Fibroblast - Dermal, donor3	11418-118F5	24.54	8.70	2.30	13.06	2.90	3.87	1.33
Fibroblast - Dermal, donor4	11450-119A1	22.38	14.58	3.62	6.78	0.57	1.58	1.58
Fibroblast - Dermal, donor5	11454-119A5	25.82	17.45	5.58	7.85	1.05	0.35	1.22
Fibroblast - Dermal, donor6	11458-119A9	25.01	19.33	3.90	6.98	0.32	0.49	3.25
Fibroblast - Gingival, donor1	11237-116D4	41.85	11.87	2.29	17.49	3.33	7.70	2.71
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	34.06	12.31	2.10	15.20	12.05	9.43	2.10
Fibroblast - Gingival, donor2	11318-117D4	27.02	13.31	4.35	11.86	2.50	3.43	1.71
Fibroblast - Gingival, donor3	11394-118C8	25.91	8.90	3.29	9.57	4.54	4.83	2.90
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	37.40	12.47	6.23	18.70	2.08	2.08	3.12
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	20.62	9.87	2.47	8.46	2.11	3.35	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	43.50	14.19	2.49	18.71	4.05	4.52	2.96
Fibroblast - Gingival, donor6 (control)	11922-125H5	39.49	12.31	2.03	20.55	7.57	7.03	2.70
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	31.41	11.65	2.47	9.88	2.12	1.41	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	50.16	13.60	3.07	18.72	4.39	4.97	2.34
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	34.91	12.54	2.05	19.09	8.86	7.50	3.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	29.73	12.40	2.63	10.86	3.73	5.16	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	31.26	15.85	8.66	10.86	3.52	2.93	1.91
Fibroblast - Lung, donor1	11270-116H1	12.23	8.16	0.00	5.44	2.72	5.44	0.00
Fibroblast - Lung, donor2	11347-117G6	17.91	8.95	1.49	5.97	14.92	2.98	0.00
Fibroblast - Lung, donor3	11419-118F6	22.16	8.44	2.95	10.97	4.01	5.28	0.84
Fibroblast - Lymphatic, donor1	11506-119G3	17.49	7.50	2.50	6.66	1.67	1.67	1.67
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	5.59	4.20	0.00	1.40	1.40	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	7.00	2.52	1.96	2.24	0.28	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	43.44	16.24	4.47	9.74	2.44	2.44	2.44
Fibroblast - Mammary, donor2	11620-122A9	15.98	3.99	0.00	7.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	59.56	5.96	5.96	5.96	5.96	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	29.48	13.77	4.27	13.38	2.72	2.13	2.72
Fibroblast - Periodontal Ligament, donor2	11319-117D5	30.49	14.71	5.61	8.95	2.43	1.21	1.97
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.43	15.61	4.59	12.55	3.06	6.12	4.59
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	28.62	11.83	1.91	12.59	3.05	1.14	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	28.35	12.42	4.32	17.55	4.05	3.24	3.24
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	22.73	9.51	1.86	10.79	2.67	3.71	1.16
Fibroblast - Pulmonary Artery, donor1	11250-116E8	22.99	14.48	4.53	10.17	2.10	3.54	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	41.65	20.93	2.84	9.75	2.24	3.86	1.63
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.71	6.01	4.68	4.01	0.67	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.47	13.05	3.95	7.12	1.19	1.19	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	9.92	7.74	1.19	2.98	2.78	2.18	0.79
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	47.60	15.81	4.62	12.61	4.44	2.49	1.60
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	43.75	15.57	3.15	16.16	3.55	3.55	3.15
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	6.92	3.01	2.11	2.41	1.81	1.20	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	40.91	18.35	3.56	20.19	5.18	7.12	2.37
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	10.38	7.85	0.51	3.80	3.29	2.53	1.77
Fibroblast - skin normal, donor1	11553-120C5	43.81	15.42	4.10	15.75	5.09	4.10	2.95
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	10.43	5.61	1.20	5.61	4.01	5.41	0.60
Fibroblast - skin normal, donor2	11561-120D4	32.45	15.57	3.11	15.87	3.42	6.23	2.01
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	8.76	7.25	1.81	2.72	0.91	1.51	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	47.39	11.60	5.55	15.74	3.31	3.73	1.82
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.29	22.22	5.47	17.10	22.74	14.02	1.88
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	9.52	3.61	0.66	2.96	3.61	2.96	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.11	17.68	3.20	16.83	5.43	7.14	2.34
Fibroblast - skin walker warburg, donor1	11554-120C6	34.58	14.17	3.20	10.29	1.86	2.02	2.36
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	42.34	12.86	4.39	13.96	9.57	6.43	2.67
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	44.32	44.32	0.00	66.48	66.48	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	4.36	28.76	8.72	0.87	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	28.26	23.75	3.99	9.19	2.60	2.43	2.08
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.41	20.04	4.68	7.29	0.78	1.56	2.08
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	28.36	22.49	6.39	6.39	0.26	3.07	4.34
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	11.48	7.66	3.06	1.53	1.53	0.00	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	13.40	8.29	3.83	1.91	1.28	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	14.55	7.70	2.00	3.42	0.29	0.00	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	12.68	12.13	5.24	1.38	0.28	0.00	0.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	23.06	15.53	4.57	2.28	0.91	0.23	1.37
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	11.29	7.73	2.97	2.38	0.20	0.20	1.19
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	10.84	11.10	3.97	0.53	0.53	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	25.44	22.83	6.85	2.94	1.63	2.28	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	9.29	4.42	3.54	1.33	0.44	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	17.52	9.75	3.96	1.70	1.70	0.14	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	20.69	15.27	4.56	3.32	1.23	0.25	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	17.46	5.64	1.07	1.07	1.61	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	20.44	22.67	4.83	3.22	1.98	0.50	1.73
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	20.90	22.70	4.71	3.18	1.66	0.83	2.08
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	16.67	8.74	2.85	3.05	1.83	0.41	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	28.98	20.76	3.42	5.25	0.91	0.00	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	23.04	16.57	4.86	3.61	1.25	0.75	2.24
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	22.51	12.46	2.84	3.28	1.09	0.87	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	36.34	12.11	3.84	4.14	2.07	1.18	2.07
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	23.68	19.23	4.77	3.50	1.75	0.79	2.23
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	24.35	11.39	2.90	2.68	1.56	0.89	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	36.29	13.91	2.82	3.63	1.41	1.21	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	26.29	23.92	4.92	5.94	2.37	1.53	2.04
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	34.76	16.85	4.43	5.14	2.39	1.60	2.39
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	22.16	7.80	4.99	0.73	3.64	1.25	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	24.42	8.71	2.90	0.85	2.39	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	27.00	25.01	5.75	3.21	1.55	1.11	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.52	16.72	4.66	5.74	2.33	1.66	1.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.14	16.54	3.47	3.68	3.47	2.25	1.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	31.77	14.65	4.33	4.95	1.44	0.41	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	29.75	22.71	6.46	3.57	1.61	1.04	1.73
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	23.51	12.17	4.34	4.84	1.50	1.00	1.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	31.08	12.34	4.85	4.19	1.54	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.06	24.48	4.55	4.80	2.09	0.37	1.60
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	28.85	17.18	4.54	3.89	2.27	0.49	0.81
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	33.35	16.68	5.13	3.21	1.92	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	21.70	18.19	5.50	1.99	0.66	0.47	0.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	25.31	14.08	3.95	3.48	1.11	0.63	0.79
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	28.89	11.86	3.34	5.47	0.91	0.61	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	21.64	22.06	5.23	4.50	1.57	1.05	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	22.83	12.95	3.29	4.61	1.54	0.88	1.32
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	22.72	15.43	3.65	2.52	0.56	0.28	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.91	14.26	2.13	2.50	0.74	0.83	1.11
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	26.21	13.37	2.94	9.09	1.07	1.60	2.41
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	20.20	13.31	2.91	4.90	0.61	0.77	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	19.17	14.51	3.11	4.92	0.39	0.78	1.55
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	27.92	11.39	3.52	5.69	1.90	0.27	1.36
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	31.16	14.75	6.27	6.64	1.47	0.74	1.84
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	27.41	14.69	3.95	3.95	2.41	0.44	0.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	29.75	22.81	10.91	2.98	0.99	0.00	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	36.94	14.38	5.14	6.33	1.45	0.79	2.11
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	30.67	12.91	4.64	6.66	1.41	0.40	1.82
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	32.79	15.00	14.23	1.52	3.56	1.02	1.52
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	16.12	9.55	2.39	1.79	1.79	0.40	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	11.40	7.09	2.62	0.92	2.00	0.46	1.23
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	13.50	10.23	2.25	2.05	1.23	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	18.15	9.39	3.44	3.13	1.25	0.00	2.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	13.85	5.37	2.26	2.26	1.41	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	12.91	7.84	0.92	1.38	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	17.32	12.37	0.00	2.47	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	17.02	8.12	2.32	2.71	1.55	0.39	2.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	12.84	14.44	1.60	4.81	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	39.99	5.22	5.22	1.74	5.22	3.48	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	17.25	7.81	1.63	3.58	1.30	0.33	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	19.77	8.24	2.06	5.35	1.24	0.82	1.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	26.66	10.00	3.33	0.00	0.00	0.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	17.06	8.95	0.84	2.80	0.84	0.84	0.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	15.69	10.13	1.31	4.58	1.63	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	13.42	8.39	5.87	3.36	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	20.67	15.59	3.18	2.23	1.59	0.32	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	19.02	10.53	1.70	2.38	0.68	0.34	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	16.71	6.26	0.00	2.09	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.20	15.46	1.72	2.86	1.15	0.57	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	27.82	10.95	2.37	3.26	1.78	0.30	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	37.27	16.94	6.78	5.08	0.00	3.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	38.52	24.02	3.73	9.94	5.80	1.66	2.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	26.23	19.79	3.22	3.91	3.68	0.92	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	31.61	10.54	0.00	21.07	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.91	18.07	2.31	6.54	3.46	2.31	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	28.69	24.12	3.91	6.19	4.56	1.63	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	27.42	15.38	3.34	6.02	4.01	0.67	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	40.84	17.34	3.85	5.39	2.70	0.39	1.54
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	38.68	27.04	1.71	6.16	3.77	3.42	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	49.70	27.33	9.94	4.97	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	30.20	22.65	6.61	4.72	3.30	0.94	1.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	47.07	19.92	9.05	4.83	3.62	0.60	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	41.20	14.24	1.53	4.58	3.56	0.51	2.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	36.29	16.75	4.79	2.79	3.19	1.20	3.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	40.46	33.55	2.96	5.43	1.97	0.99	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	36.59	17.71	4.72	12.98	2.36	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	42.01	21.59	6.42	7.00	1.75	0.00	2.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	46.52	26.33	5.71	7.46	3.95	0.88	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	34.76	30.52	0.85	5.93	5.09	0.00	3.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	38.80	18.50	1.19	6.57	5.97	0.60	1.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	29.11	27.66	0.97	8.25	4.37	0.00	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	30.82	7.99	4.57	9.13	0.00	4.57	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	37.42	10.40	3.74	13.72	3.33	2.49	3.74
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	30.36	14.62	4.50	12.37	2.25	3.37	6.75
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	25.37	13.32	5.39	7.61	3.81	4.12	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	20.47	9.61	3.76	10.44	6.68	2.92	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	18.57	12.07	2.32	7.19	5.11	4.76	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	19.58	10.47	1.69	5.06	3.04	2.19	1.18
Hep-2 cells mock treated, biol_rep3	11900-125F1	18.43	12.97	2.05	5.46	3.87	2.50	0.91
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.44	9.84	2.08	6.12	4.37	2.51	1.86
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	18.91	11.61	1.50	4.08	5.16	4.08	1.50
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	20.24	10.98	1.51	5.60	3.23	1.94	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	15.69	9.22	1.12	4.98	4.11	4.61	1.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	16.81	9.26	1.37	6.86	2.40	1.89	1.54
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	17.94	6.73	1.28	5.77	3.20	1.92	0.96
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	20.71	26.30	4.48	8.95	1.12	1.68	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	10.82	9.52	3.46	4.33	0.00	0.43	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	13.22	0.00	15.86	0.00	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	26.10	20.46	7.05	6.00	1.41	2.47	1.41
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	15.26	7.99	3.63	8.72	3.63	1.45	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	15.04	14.51	3.15	5.42	3.32	2.62	0.52
Hepatocyte, donor1	11523-119I2	7.26	4.84	0.00	2.42	7.26	4.84	1.21
Hepatocyte, donor2	11603-120I1	9.70	5.39	2.15	9.70	3.23	4.31	0.00
Hepatocyte, donor3	11684-122I1	3.68	3.07	0.61	3.07	2.45	1.84	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	13.71	14.36	0.00	1.31	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	42.65	17.48	1.75	9.61	14.68	6.29	2.45
Iris Pigment Epithelial Cells, donor1	11530-119I9	18.93	10.02	5.21	3.70	0.41	0.82	1.23
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	3.18	0.00	3.18	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	6.68	0.00	0.00	0.00	0.00	6.68
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	5.54	5.54	0.00	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	0.00	2.50	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	11.87	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	5.13	0.00	0.00	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	12.99	6.50	1.62	4.87	0.00	1.62	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	1.67	3.33	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	3.63	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	6.62	6.62	1.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	4.43	4.43	1.11	1.11	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	0.00	5.24	0.00	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	7.56	3.15	0.63	3.15	0.00	0.63	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	9.28	0.00	0.00	1.55	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	14.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	8.40	6.46	1.29	0.65	0.65	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	19.32	1.61	4.83	0.00	0.00	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	4.89	7.33	1.63	1.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	4.62	5.46	2.10	3.36	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	14.37	14.37	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	9.64	4.02	3.21	0.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	3.69	1.85	0.00	0.92	0.00	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	4.25	5.66	1.42	1.89	0.47	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	9.07	3.63	0.91	0.00	0.00	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	8.61	4.30	4.30	1.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	6.35	6.35	1.27	0.00	1.27	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	6.38	2.55	1.91	2.55	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	3.65	5.47	1.82	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	31.61	0.00	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	3.57	7.85	0.00	0.00	0.71	0.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	3.32	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	11.11	6.17	1.54	1.85	0.93	0.62	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	3.51	1.76	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	12.57	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	7.65	4.17	1.39	1.39	0.00	0.00	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	11.07	8.85	0.00	0.00	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	9.73	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	6.98	6.10	1.74	0.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	0.00	2.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	7.47	7.47	1.07	0.00	2.13	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	1.39	1.39	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	0.00	0.00	2.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	6.44	5.52	2.76	2.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	6.05	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	18.63	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	4.23	6.34	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	11.67	16.16	7.02	2.37	0.98	0.57	2.45
Keratinocyte - epidermal, donor2	11349-117G8	8.78	24.60	11.13	0.59	0.00	1.17	0.59
Keratinocyte - epidermal, donor3	11421-118F8	6.82	23.57	11.93	0.38	0.47	0.00	0.76
Keratinocyte - oral, donor1	11251-116E9	14.19	30.54	16.80	1.14	1.36	0.11	1.48
Keratocytes, donor1	11527-119I6	27.16	14.44	5.16	8.94	2.06	1.38	1.03
Keratocytes, donor2	11607-120I5	19.92	10.55	2.34	7.03	2.34	2.34	2.34
Keratocytes, donor3	11688-122I5	18.38	6.92	3.16	4.35	2.37	3.16	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	6.59	0.00	0.00	0.00	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	14.02	12.94	4.31	5.39	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	41.87	31.60	10.03	6.80	1.15	0.81	2.88
Lens Epithelial Cells, donor3	11690-122I7	15.64	16.75	6.56	3.43	0.30	0.50	2.32
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	38.42	43.99	5.34	14.82	2.73	2.37	5.45
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	23.72	19.81	6.42	11.72	1.95	0.28	2.51
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	29.91	35.58	5.98	7.87	2.52	1.89	3.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	29.57	33.88	2.15	11.83	1.08	2.15	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	33.09	26.79	4.41	8.82	1.89	1.58	2.84
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.44	30.19	4.96	9.27	1.08	2.05	2.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.21	31.60	4.10	9.44	2.46	1.23	4.10
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	24.02	22.00	4.55	8.60	1.52	1.01	2.78
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	21.68	28.29	2.96	8.30	1.83	2.11	2.96
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	19.78	28.87	4.75	7.52	0.40	0.79	3.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	25.20	26.76	3.10	9.31	2.13	1.36	2.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	22.40	21.66	3.15	6.85	0.93	0.74	2.41
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	31.01	32.06	3.48	11.85	2.09	1.39	3.14
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.67	21.94	4.29	7.63	1.67	1.19	2.86
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	22.66	25.96	3.30	9.06	2.61	1.79	2.33
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	30.49	32.03	3.39	9.85	4.00	1.23	2.77
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	16.21	22.76	2.49	5.30	1.87	0.94	2.18
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	22.87	31.47	4.39	8.78	1.83	2.01	2.20
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	25.67	34.23	3.62	9.54	2.63	1.65	3.95
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	24.02	20.21	3.51	10.25	2.34	0.59	2.64
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	18.42	22.40	3.24	7.97	1.00	1.24	2.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.61	31.04	6.79	7.76	0.97	0.48	2.91
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	26.12	24.51	3.23	9.96	1.62	2.96	3.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	27.40	30.43	3.63	8.63	2.27	1.82	3.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	26.44	27.48	4.67	9.33	3.11	1.56	2.59
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	29.31	30.57	5.86	12.14	1.88	1.05	1.88
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	22.56	27.07	3.01	9.17	1.50	1.95	3.16
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	17.88	28.89	2.75	6.88	2.06	3.44	1.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.34	23.14	3.76	8.28	0.94	2.82	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.05	21.74	4.77	8.80	2.44	2.01	2.12
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	28.11	26.65	5.33	12.11	1.94	2.42	0.97
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.51	20.51	3.97	7.61	2.65	1.65	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.55	23.42	2.48	6.69	1.73	2.60	2.23
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	29.62	28.14	2.96	4.81	1.48	2.22	3.33
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	23.23	25.20	2.96	10.13	1.24	1.48	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	17.87	20.35	2.61	7.70	1.24	2.20	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.12	31.20	5.15	9.01	1.93	2.25	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.39	23.13	5.17	10.04	1.22	2.13	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	23.65	21.69	3.78	9.94	2.10	1.68	3.22
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	20.98	27.38	4.62	9.24	1.07	0.71	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.33	19.39	4.36	6.79	0.97	2.42	1.94
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	16.18	17.74	2.02	5.60	1.24	1.24	2.49
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	22.92	25.07	2.51	8.59	2.15	4.30	3.22
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	22.54	22.87	3.27	11.43	1.63	3.92	2.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	19.30	20.95	1.65	5.89	0.94	1.18	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.15	29.08	3.59	13.86	2.48	2.60	3.59
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	16.90	15.88	3.33	6.40	1.28	1.28	2.05
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.48	26.85	2.09	7.46	0.30	1.79	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	15.86	9.06	0.00	2.27	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	4.60	16.88	3.07	1.53	1.53	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	5.94	10.39	2.23	0.74	3.71	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	5.92	7.62	2.54	0.42	0.85	0.85	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	3.52	10.55	2.81	1.41	3.52	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	2.80	4.67	0.93	2.80	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	4.64	5.67	1.55	1.55	1.55	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	9.52	11.89	2.38	0.00	1.19	2.38	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	7.69	12.21	3.17	1.58	1.36	0.90	1.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	6.98	11.34	2.04	0.87	1.74	0.29	1.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	7.20	7.20	3.60	0.90	3.15	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	8.94	12.46	4.06	1.35	1.63	0.54	1.90
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	7.19	6.16	4.62	1.03	2.05	0.51	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	6.00	13.41	1.76	2.12	1.41	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	5.33	5.33	0.67	1.33	0.00	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	6.62	9.68	4.58	1.53	1.02	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	5.87	11.74	1.07	0.53	1.60	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	6.42	8.88	2.65	0.94	2.65	0.00	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	8.59	7.98	2.45	0.61	2.45	1.84	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	4.08	12.23	2.45	1.63	3.26	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	4.58	9.79	2.71	0.42	1.87	0.42	0.83
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	6.45	10.65	0.84	1.96	3.08	1.12	0.84
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	9.27	1.03	2.06	0.00	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	7.84	11.03	3.19	1.74	3.19	1.45	1.74
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	8.67	7.47	1.79	0.60	2.09	0.30	1.49
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	7.75	11.07	1.11	1.11	1.66	1.11	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	6.01	10.60	2.12	2.12	1.41	0.35	2.12
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	6.64	8.85	2.95	1.11	1.84	0.74	1.11
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	5.76	12.66	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	7.29	9.98	1.92	1.92	1.15	0.00	2.30
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	7.93	6.79	1.13	1.13	2.26	1.13	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	6.56	9.85	3.28	0.00	1.64	1.64	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	6.33	10.85	2.71	2.71	1.81	0.00	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	9.34	2.15	1.44	2.87	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	8.96	8.96	3.73	2.24	1.49	0.00	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.92	11.52	4.09	1.11	2.23	0.00	0.74
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	8.18	10.77	1.29	1.29	2.58	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.14	5.14	1.71	1.71	1.71	2.57	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	6.66	8.66	2.00	1.33	1.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.24	8.45	1.81	1.21	2.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	8.53	10.66	0.71	0.71	2.13	0.71	1.42
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	6.19	7.91	1.72	1.72	2.06	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	5.37	8.05	1.07	0.54	2.15	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.71	10.10	2.69	0.00	1.35	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	7.41	10.74	3.33	1.11	2.96	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	13.96	11.63	3.49	1.16	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	4.23	6.35	3.17	1.06	1.06	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	4.00	11.20	2.00	1.60	2.40	1.20	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	4.36	13.08	4.36	1.45	2.18	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	6.90	14.56	4.60	0.77	0.00	1.53	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	12.33	9.37	2.96	1.48	0.99	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	9.41	0.94	2.82	3.76	0.00	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	4.53	11.56	2.01	3.02	2.51	0.50	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	7.66	10.36	2.70	0.00	0.90	1.35	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	6.88	6.88	1.72	0.00	3.44	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	6.23	11.13	4.01	0.89	2.67	0.89	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	8.99	9.38	3.13	1.56	3.52	0.39	1.17
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	5.94	9.24	0.66	1.98	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	9.34	9.34	6.23	0.52	2.08	1.04	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	12.25	10.94	3.50	1.31	2.19	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	7.83	9.50	1.12	0.00	2.24	0.00	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	4.86	7.95	1.77	0.88	1.77	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	6.17	13.89	4.63	1.93	0.39	0.39	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	6.08	7.60	1.52	0.00	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	6.25	12.02	0.96	1.44	3.36	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	10.34	9.94	2.78	0.80	1.59	0.80	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	7.29	14.58	3.04	1.22	1.82	0.61	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	5.53	6.92	1.38	0.69	0.69	0.00	0.69
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	5.70	9.88	2.66	1.90	2.66	1.14	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	11.88	14.98	1.03	2.58	2.07	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	5.44	10.88	0.60	0.60	0.00	1.21	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	5.70	11.73	4.75	1.27	1.27	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	5.86	14.39	3.73	0.00	1.60	0.53	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	2.87	13.22	0.57	0.00	1.72	1.72	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	7.20	8.23	3.09	2.06	1.54	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.78	8.49	3.54	1.41	1.41	0.71	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	8.51	11.35	2.84	1.70	1.70	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	8.32	14.98	2.50	1.66	4.16	1.25	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	8.61	11.75	5.48	2.35	1.57	0.00	0.78
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	5.01	12.53	0.00	0.84	2.09	0.84	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	7.43	9.29	2.79	2.32	1.39	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	8.70	10.70	0.67	0.00	1.34	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.74	7.48	3.21	1.07	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	4.85	8.49	2.02	2.02	3.23	0.40	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	4.59	9.18	2.75	0.92	1.84	0.92	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	3.56	10.67	1.78	0.89	1.78	1.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	5.70	9.69	2.85	0.00	0.00	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	8.44	6.90	1.53	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	5.47	12.59	1.09	0.55	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	7.13	10.25	1.34	0.89	0.00	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	12.48	13.00	2.34	2.60	1.04	0.00	0.78
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	3.98	3.32	2.65	2.65	1.33	1.33	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	6.24	8.31	2.08	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	33.28	8.20	1.60	6.15	0.46	1.14	1.37
Macrophage - monocyte derived, donor2	11313-117C8	36.15	9.73	3.12	6.79	0.37	0.73	1.84
Macrophage - monocyte derived, donor3	11389-118C3	36.44	6.42	1.70	6.69	0.79	0.92	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	19.65	19.65	5.84	6.90	1.59	2.66	2.66
Mallassez-derived cells, donor2	11929-125I3	35.02	15.21	2.54	10.77	2.06	6.02	2.22
Mallassez-derived cells, donor3	11930-125I4	22.52	20.43	6.12	5.84	1.67	2.36	1.81
Mammary Epithelial Cell, donor1	11273-116H4	23.22	32.78	8.17	7.97	3.99	2.69	2.59
Mammary Epithelial Cell, donor2	11350-117G9	24.61	32.72	6.66	6.37	2.03	2.32	2.32
Mammary Epithelial Cell, donor3	11422-118F9	16.46	21.70	6.24	4.99	0.25	1.00	1.25
Mast cell - stimulated, donor1	11487-119E2	10.85	1.36	1.36	1.36	2.71	1.36	0.00
Mast cell, donor1	11563-120D6	45.20	14.27	4.43	8.11	1.51	1.84	2.05
Mast cell, donor2	11565-120D8	47.85	14.26	7.13	5.94	1.19	1.49	1.78
Mast cell, donor3	11566-120D9	54.71	18.01	8.10	6.08	2.70	1.35	1.13
Mast cell, donor4	11567-120E1	42.90	16.84	7.27	4.79	2.66	0.89	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	78.51	14.86	3.88	14.19	2.33	1.77	1.89
Mast cell, expanded and stimulated, donor8	11942-126A7	57.78	14.59	2.92	14.01	0.00	0.58	4.09
Mast cell, expanded, donor5	11939-126A4	63.21	14.23	4.13	11.24	1.61	0.80	2.06
Mast cell, expanded, donor8	11941-126A6	61.42	12.22	4.02	11.55	1.67	0.17	1.84
Melanocyte - dark, donor1	11502-119F8	33.63	15.92	3.28	9.95	1.89	1.49	2.29
Melanocyte - dark, donor2	11582-120F7	19.03	11.42	2.42	6.58	1.73	1.38	1.38
Melanocyte - dark, donor3	11663-122F7	20.14	11.81	5.72	2.75	0.29	0.58	1.30
Melanocyte - light, donor1	11274-116H5	13.16	8.23	3.53	4.00	0.71	0.47	0.94
Melanocyte - light, donor2	11351-117H1	13.65	8.87	2.73	1.36	0.68	0.00	0.68
Melanocyte - light, donor3	11423-118G1	5.20	1.73	4.34	6.07	0.87	0.87	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	18.22	10.20	4.06	3.75	0.94	0.52	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	18.02	11.30	3.50	3.23	1.34	0.54	1.34
Melanocyte, donor3 (MC+3)	12837-137B2	26.52	9.91	4.02	3.48	0.54	0.80	1.07
Meningeal Cells, donor1	11493-119E8	27.29	22.08	5.09	5.71	1.24	1.24	1.98
Meningeal Cells, donor2	11573-120E7	18.05	23.33	2.64	4.84	0.88	0.88	0.88
Meningeal Cells, donor3	11654-122E7	22.74	13.20	4.97	4.89	0.82	1.47	1.79
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	33.65	17.68	6.56	9.41	2.28	2.28	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.36	8.75	3.02	7.25	1.31	1.81	1.51
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	7.88	5.26	0.00	0.00	2.63	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	6.54	5.23	2.62	7.85	0.00	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	30.86	7.18	2.15	9.33	1.44	2.87	4.31
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	22.66	16.52	4.02	6.56	2.54	3.18	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	21.11	7.54	2.51	6.03	3.02	4.52	2.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.01	11.65	2.42	5.49	0.44	2.20	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	18.26	10.23	3.65	5.84	0.73	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	18.01	9.62	2.25	5.32	1.23	0.41	1.84
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	33.38	15.24	4.99	13.57	3.60	2.49	2.49
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	15.24	6.32	1.86	2.23	0.74	0.74	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	44.47	16.84	5.53	14.74	4.61	3.29	2.63
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	11.57	7.42	1.19	7.12	3.86	1.48	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	9.34	4.67	2.34	0.00	9.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	21.77	8.33	1.92	5.12	0.64	0.64	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	32.96	13.11	4.25	16.30	1.06	3.54	3.19
Mesenchymal stem cells - hepatic, donor0	11218-116B3	40.34	15.64	5.32	13.76	1.56	4.38	2.19
Mesenchymal stem cells - umbilical, donor0	11214-116A8	18.87	7.26	1.45	2.18	1.45	2.18	0.00
Mesothelial Cells, donor1	11247-116E5	23.34	13.26	3.71	8.75	1.59	1.86	2.39
Mesothelial Cells, donor2	12156-128G5	23.02	18.02	2.00	11.51	1.00	2.50	5.00
Mesothelial Cells, donor3	11402-118D7	22.91	10.48	3.90	5.35	1.73	2.89	2.02
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	0.00	1.35	2.70	1.35	1.35	2.70
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	36.45	10.59	2.46	5.91	0.99	0.99	3.94
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	39.16	7.95	2.06	8.24	0.59	1.18	2.94
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	24.20	6.91	3.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	35.95	6.51	1.55	5.58	0.93	0.62	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	30.29	4.56	1.87	8.09	1.45	0.41	1.45
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	20.84	2.32	4.63	2.32	0.00	0.00	2.32
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	30.78	7.51	1.50	6.01	0.75	0.50	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	37.24	6.05	4.65	6.52	0.47	0.47	3.26
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	25.40	8.13	1.22	6.71	2.24	0.41	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	33.26	6.34	1.58	5.54	1.19	0.40	0.79
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	0.00	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	23.01	3.54	2.65	2.65	2.65	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	27.74	7.98	1.52	9.50	0.00	0.38	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	27.63	9.21	3.95	6.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	25.47	8.70	1.27	6.15	0.85	0.21	1.91
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	24.86	3.68	0.92	4.60	0.00	0.00	1.84
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	23.25	4.77	1.49	4.77	0.00	0.00	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	16.77	1.68	0.00	6.71	0.00	1.68	5.03
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	33.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	22.08	6.02	1.76	5.27	0.75	1.00	1.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	23.53	6.89	1.66	4.75	0.24	0.95	1.66
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	15.48	1.11	2.21	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	20.95	7.83	1.38	5.07	0.23	1.38	0.69
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	24.40	8.62	0.84	7.78	0.21	0.63	1.26
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	14.88	6.93	3.26	4.48	0.00	1.02	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	22.96	4.93	0.86	3.86	0.86	0.86	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	24.23	5.56	0.89	6.45	0.44	0.89	0.89
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	10.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	15.99	6.13	1.53	5.26	0.66	1.53	1.10
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	15.72	4.56	2.03	4.56	0.00	1.52	2.53
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	19.88	4.97	0.00	4.97	3.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	22.56	7.61	0.54	3.53	0.82	0.82	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	22.06	3.82	2.65	6.47	0.29	1.18	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	19.63	6.54	2.18	6.54	1.09	0.00	2.18
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	16.82	5.29	1.44	3.84	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	24.01	13.21	2.40	6.40	0.80	1.60	1.60
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	2.74	0.00	6.86	0.00	1.37	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	17.52	15.52	2.50	6.51	0.00	0.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	2.04	0.00	0.00	4.08	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	17.95	15.77	0.44	9.63	2.19	0.88	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	6.62	1.10	1.10	0.00	0.00	3.31
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	15.37	7.04	3.84	2.56	0.00	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	27.27	8.43	0.74	4.46	0.74	1.24	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	20.18	11.83	2.09	2.09	0.70	0.00	1.39
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	17.68	6.63	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	25.30	14.36	1.71	8.21	0.68	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.51	9.63	1.31	2.63	0.00	1.31	2.19
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.23	5.68	1.78	4.97	0.71	1.07	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	27.49	11.50	1.68	10.10	0.84	2.24	1.40
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	27.85	10.81	2.91	3.33	0.83	1.25	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	16.90	4.66	2.33	4.08	0.00	0.58	2.33
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	24.43	13.88	2.11	7.24	1.51	1.21	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	28.80	12.10	1.25	7.93	0.83	0.42	3.34
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	36.09	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	24.01	10.16	0.92	8.31	1.85	0.92	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	25.04	14.80	0.57	5.69	1.14	0.57	2.28
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	12.85	6.36	2.07	4.70	0.28	0.69	1.80
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	20.21	9.07	2.59	7.26	0.26	1.04	0.78
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	26.17	11.15	0.86	6.43	0.86	0.43	3.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	20.33	5.08	1.91	3.81	0.00	0.00	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	20.02	10.14	0.53	3.47	0.27	0.53	1.60
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	32.93	15.86	2.39	13.47	1.20	0.90	2.99
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	13.56	10.03	2.83	4.10	0.14	1.13	2.40
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	21.02	14.01	2.87	6.05	0.64	1.27	1.59
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	30.07	13.71	2.21	8.18	0.88	0.88	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	17.82	9.86	2.28	6.45	0.00	0.38	2.28
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	22.73	12.50	1.42	4.83	1.14	1.99	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	24.33	15.73	3.20	6.88	0.74	1.23	1.72
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	21.51	7.82	2.61	6.52	0.00	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	26.17	17.94	3.82	6.17	0.29	1.18	4.70
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	33.16	22.20	1.44	9.23	0.86	3.75	4.90
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	36.68	26.38	7.42	5.77	1.24	0.41	2.89
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	29.48	18.16	2.38	6.85	1.19	0.30	2.38
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	11.30	7.53	11.30	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	21.39	8.91	3.56	7.13	0.00	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	28.26	5.26	1.64	6.24	2.63	0.66	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	23.14	5.26	0.00	6.31	0.00	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	33.21	6.13	1.78	7.12	0.20	0.40	0.99
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	31.66	3.73	4.66	4.66	0.93	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	37.18	9.01	3.00	9.39	1.50	2.25	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.23	4.00	2.93	4.26	1.33	0.00	1.33
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	32.23	7.92	2.04	5.77	0.79	0.68	1.02
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	18.42	5.89	0.74	4.42	1.47	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	33.71	4.40	2.20	6.96	1.10	1.10	1.83
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	6.22	3.11	10.89	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	51.84	8.55	3.21	7.48	0.53	2.14	2.14
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	15.46	0.00	3.86	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	28.28	6.06	0.00	8.08	0.00	1.01	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	35.42	6.75	0.84	5.06	3.37	2.95	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	38.13	16.34	5.45	10.90	1.36	0.00	4.09
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	24.80	4.45	2.54	6.99	0.00	1.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	46.16	10.53	0.81	7.29	3.24	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	43.80	6.04	1.51	3.02	1.51	1.51	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	28.55	0.00	11.42	11.42	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	29.36	13.05	9.79	6.52	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	9.50	4.75	9.50	4.75	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	25.10	12.55	12.55	12.55	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	24.34	14.43	5.60	5.17	2.80	2.15	2.15
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	26.65	13.59	7.32	7.32	3.14	2.61	1.05
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	21.36	2.67	0.67	18.02	1.33	2.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	20.03	5.43	0.42	9.60	1.25	5.01	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	45.44	13.50	2.28	18.06	4.56	12.93	2.28
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	11.17	1.60	0.00	7.98	1.60	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	14.96	2.72	0.68	12.24	2.04	1.36	0.68
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	47.78	9.19	5.51	12.86	3.68	14.70	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	18.83	5.44	1.26	8.37	0.84	2.09	1.26
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	32.54	8.14	1.63	15.81	5.81	6.51	3.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	25.67	5.67	2.16	13.51	2.97	1.89	1.62
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	28.17	11.56	0.84	8.83	1.26	4.84	2.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	0.00	11.13	44.54	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	24.82	4.96	1.49	14.89	1.99	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	36.00	6.50	0.81	19.49	4.60	6.50	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.85	7.48	1.59	17.45	3.85	2.04	1.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	19.76	4.57	1.63	10.94	2.94	2.45	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	24.79	8.57	1.28	13.85	4.56	3.65	1.82
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	27.05	2.65	1.59	16.97	4.24	6.37	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	14.41	1.80	1.20	15.01	1.80	3.60	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	47.26	10.50	2.30	20.68	12.47	11.81	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.30	5.37	1.95	14.80	2.44	3.74	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	24.69	4.94	0.35	14.11	3.53	3.17	0.88
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	28.13	3.52	4.22	8.44	2.81	2.81	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	26.20	10.11	1.38	16.09	2.30	3.68	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	30.53	6.11	1.61	16.39	4.50	3.53	0.96
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	43.46	13.80	2.76	21.38	20.35	20.35	2.76
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	63.21	12.64	7.59	25.28	7.59	15.17	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	21.83	5.57	2.01	12.03	2.23	2.23	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	30.48	4.23	0.85	12.70	2.96	1.69	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	25.63	7.60	1.42	12.82	5.46	6.65	1.90
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	34.34	7.73	2.15	19.32	3.00	1.72	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	18.06	18.06	9.03	0.00	18.06	18.06	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	24.66	4.67	0.67	11.33	3.67	1.67	1.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	13.53	2.71	0.90	13.08	1.80	0.90	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.63	6.75	1.19	15.87	3.17	1.59	1.98
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	4.64	0.93	14.86	2.79	8.36	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	43.89	7.57	2.65	28.00	3.41	4.54	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	23.14	5.54	1.30	14.34	2.28	2.28	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	12.20	2.61	0.87	8.28	2.18	1.31	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	25.33	4.98	0.90	12.66	2.26	4.07	2.26
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	29.10	0.88	0.88	8.82	1.76	3.53	5.29
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	25.93	2.66	1.33	15.29	5.98	3.32	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	29.76	4.46	0.99	20.34	3.47	1.98	2.98
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	23.74	6.13	3.45	13.02	1.91	1.53	1.53
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	17.24	5.44	2.72	11.19	2.42	1.21	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	31.83	8.40	2.21	13.26	2.43	3.76	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	3.39	1.36	12.20	1.36	3.39	2.03
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	45.99	15.33	10.22	10.22	30.66	15.33	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	5.49	3.66	14.02	4.27	2.44	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.86	5.04	2.52	12.27	1.57	2.83	2.52
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	16.95	4.54	1.51	5.75	2.12	2.72	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	29.27	5.54	1.58	11.08	0.00	2.37	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	47.61	6.80	2.27	22.67	15.87	10.20	4.53
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	85.98	0.00	0.00	10.12	20.23	25.29	0.00
Myoblast, donor1	11241-116D8	41.00	13.29	2.98	19.50	4.72	6.09	4.72
Myoblast, donor2	11322-117D8	19.56	7.67	2.30	13.62	3.45	4.41	2.49
Myoblast, donor3	11398-118D3	39.52	13.79	3.03	15.47	2.02	4.04	3.20
NK T cell leukemia cell line:KHYG-1	10777-110G3	17.51	20.58	9.19	1.90	1.02	0.58	1.17
Natural Killer Cells, donor1	11230-116C6	10.46	21.53	32.29	2.15	1.23	0.62	0.62
Natural Killer Cells, donor2	11311-117C6	5.13	16.89	32.57	0.90	1.21	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	9.39	20.80	28.53	0.92	0.92	0.00	0.74
Neural stem cells, donor1	11275-116H6	46.09	33.75	6.90	3.99	3.27	2.18	4.72
Neural stem cells, donor2	11352-117H2	9.63	19.26	36.59	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	10.24	39.83	29.59	2.28	2.28	0.00	0.00
Neurons, donor2	11574-120E8	12.11	28.40	29.72	2.42	1.76	0.88	1.76
Neurons, donor3	11655-122E8	9.87	33.71	27.95	4.93	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	5.57	3.71	6.50	0.00	0.93	0.00	0.93
Neutrophils, donor2	11314-117C9	11.60	5.80	2.90	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	4.28	7.94	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	36.10	17.34	6.53	12.35	4.63	4.27	2.14
Nucleus Pulposus Cell, donor2	11409-118E5	21.82	5.54	2.28	7.81	2.93	0.65	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	17.45	10.43	4.01	10.23	2.41	1.80	2.01
Olfactory epithelial cells, donor1	11933-125I7	25.47	9.64	3.44	20.51	4.13	2.20	2.34
Olfactory epithelial cells, donor2	11934-125I8	41.98	12.16	2.46	19.97	6.66	4.78	3.18
Olfactory epithelial cells, donor3	11935-125I9	42.79	11.01	4.09	17.37	4.31	3.63	2.61
Olfactory epithelial cells, donor4	11936-126A1	35.45	9.74	2.92	19.09	4.87	3.90	1.27
Oligodendrocyte - precursors, donor1	11496-119F2	21.67	27.68	2.41	5.42	5.42	6.02	3.01
Osteoblast - differentiated, donor1	11276-116H7	30.20	15.10	7.66	8.51	3.19	3.83	2.13
Osteoblast - differentiated, donor2	11353-117H3	3.43	4.57	0.00	1.14	1.14	1.14	1.14
Osteoblast - differentiated, donor3	11425-118G3	14.28	4.34	2.48	4.97	3.72	3.72	2.48
Osteoblast, donor1	11277-116H8	19.54	13.49	4.50	4.30	1.37	1.76	2.15
Osteoblast, donor2	11354-117H4	28.09	12.64	5.62	9.13	2.81	2.11	0.70
Osteoblast, donor3	11426-118G4	26.48	15.64	4.62	9.24	1.78	2.67	2.31
Pancreatic stromal cells, donor1	11249-116E7	30.07	12.47	3.87	13.90	10.36	9.52	2.44
Pericytes, donor1	11491-119E6	10.01	9.79	2.23	0.89	0.11	0.00	0.89
Pericytes, donor2	11571-120E5	8.83	8.38	2.94	1.13	0.68	0.00	0.91
Pericytes, donor3	11652-122E5	14.44	5.70	3.26	4.27	1.63	1.02	1.02
Perineurial Cells, donor1	11499-119F5	26.90	14.69	3.62	7.01	2.37	1.92	2.03
Perineurial Cells, donor2	11579-120F4	27.70	12.61	4.05	9.20	1.93	1.47	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	20.72	17.85	23.59	5.42	0.96	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	12.00	6.86	12.73	2.20	0.98	0.24	0.49
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.00	9.71	16.57	1.42	0.26	0.39	0.13
Placental Epithelial Cells, donor1	11278-116H9	7.65	16.74	6.22	1.43	0.24	0.48	0.24
Placental Epithelial Cells, donor2	11355-117H5	8.87	16.63	4.44	2.22	1.11	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	4.32	12.37	5.89	0.20	0.20	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	29.43	8.86	1.90	21.52	4.43	3.16	1.58
Preadipocyte - breast, donor1	11467-119B9	23.45	9.57	3.38	9.75	7.32	3.56	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	8.09	4.05	1.17	3.26	2.48	2.48	0.39
Preadipocyte - breast, donor2	11328-117E5	23.42	11.03	3.38	10.81	5.85	3.15	1.13
Preadipocyte - omental, donor1	11468-119C1	23.02	10.23	4.80	7.46	5.65	3.52	1.60
Preadipocyte - omental, donor2	11329-117E6	31.86	12.66	3.06	14.84	6.11	2.62	2.18
Preadipocyte - omental, donor3	11403-118D8	25.07	9.02	2.86	11.32	3.87	3.44	1.86
Preadipocyte - perirenal, donor1	11469-119C2	13.78	14.76	2.95	10.83	6.89	3.94	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	40.54	16.89	2.76	11.36	3.69	7.06	2.46
Preadipocyte - subcutaneous, donor2	11356-117H6	35.95	13.46	2.48	15.76	1.24	4.60	2.83
Preadipocyte - subcutaneous, donor3	11428-118G6	32.52	14.13	4.77	14.30	4.26	4.26	2.55
Preadipocyte - visceral, donor1	11280-116I2	44.06	14.16	4.28	19.19	4.56	6.43	4.19
Preadipocyte - visceral, donor2	11357-117H7	23.93	8.28	2.76	10.58	1.38	0.92	1.84
Preadipocyte - visceral, donor3	11429-118G7	25.50	8.99	1.99	15.88	2.93	4.18	1.88
Prostate Epithelial Cells (polarized), donor1	11253-116F2	42.09	15.09	2.72	9.81	9.35	5.58	2.26
Prostate Epithelial Cells, donor2	11331-117E8	18.55	20.99	4.47	4.60	1.62	1.90	2.98
Prostate Epithelial Cells, donor3	11404-118D9	7.59	10.23	6.12	2.14	1.04	1.16	0.31
Prostate Stromal Cells, donor1	11254-116F3	30.87	15.95	2.39	12.98	4.21	5.47	2.85
Prostate Stromal Cells, donor2	11332-117E9	27.97	12.73	3.05	13.27	3.05	2.69	2.33
Prostate Stromal Cells, donor3	11405-118E1	26.38	11.89	5.32	11.89	4.69	3.65	2.29
Renal Cortical Epithelial Cells, donor1	11516-119H4	14.23	13.14	4.01	1.82	0.73	1.09	0.73
Renal Cortical Epithelial Cells, donor2	11596-120H3	21.21	12.48	3.47	4.23	0.55	0.42	1.73
Renal Epithelial Cells, donor1	11517-119H5	10.14	13.19	2.03	1.01	0.51	1.01	0.51
Renal Epithelial Cells, donor2	11597-120H4	4.27	7.82	6.40	1.42	2.13	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	26.78	13.44	5.82	4.34	1.69	1.16	0.95
Renal Glomerular Endothelial Cells, donor1	11514-119H2	17.02	23.83	4.77	7.49	0.00	1.36	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	28.03	20.89	4.31	10.78	1.35	1.75	1.62
Renal Glomerular Endothelial Cells, donor3	11675-122H1	25.31	16.43	1.11	5.33	1.11	2.22	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	11.31	8.65	1.33	1.33	0.67	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	18.71	14.31	5.28	3.96	0.66	0.22	1.54
Renal Mesangial Cells, donor2	11598-120H5	28.21	18.18	8.78	3.76	1.25	1.25	1.25
Renal Mesangial Cells, donor3	11679-122H5	9.71	6.66	4.44	1.94	0.28	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	26.57	20.94	4.83	4.56	1.34	2.42	1.61
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	13.49	12.65	3.80	6.33	0.42	0.42	1.69
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	18.71	14.27	2.70	4.24	0.58	0.39	1.16
Retinal Pigment Epithelial Cells, donor0	11215-116A9	30.34	11.15	6.22	6.48	1.30	2.07	2.59
Retinal Pigment Epithelial Cells, donor1	11528-119I7	15.35	7.67	2.84	1.71	0.57	0.28	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	6.17	7.20	1.03	1.03	0.00	1.03	2.06
Retinal Pigment Epithelial Cells, donor3	11689-122I6	13.80	9.79	4.77	4.01	1.76	0.25	2.01
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	16.70	11.76	6.15	7.48	5.35	4.41	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	20.55	8.93	0.89	7.15	0.00	0.89	1.79
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	14.31	3.85	0.55	1.65	9.36	3.30	1.65
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	21.46	2.90	0.00	2.32	4.06	1.16	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	31.21	12.22	0.65	4.81	0.52	1.04	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	24.93	8.84	1.29	5.96	1.29	1.29	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	32.23	11.60	2.23	6.02	1.12	1.45	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	25.55	10.92	0.99	5.33	1.98	2.48	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	27.27	8.86	1.17	5.71	1.17	1.52	1.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	25.42	10.63	1.62	4.39	1.62	1.39	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	17.39	8.21	0.68	3.01	1.10	1.37	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	20.72	7.11	2.12	4.69	1.66	0.76	1.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	29.75	7.88	1.61	5.20	1.43	1.08	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	17.65	5.45	1.00	4.02	1.29	1.72	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	22.86	6.12	1.29	4.40	1.29	1.93	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	21.91	7.74	2.88	3.54	2.21	2.21	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	19.12	6.50	0.19	3.44	0.38	0.96	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	23.29	8.94	0.93	6.52	0.65	1.40	1.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	34.76	10.33	2.07	5.26	1.13	2.25	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	26.14	10.09	0.27	4.38	1.06	2.39	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	24.04	9.05	0.88	4.09	0.39	1.46	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	28.64	7.64	1.72	4.96	1.34	1.53	1.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	17.83	8.97	0.64	4.49	1.50	1.28	1.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	20.74	5.05	1.12	4.77	0.56	0.84	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	22.39	5.64	1.03	4.79	1.03	1.03	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	20.42	7.66	0.55	5.11	1.09	1.28	1.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	20.36	8.34	0.86	5.52	0.74	1.35	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	26.33	10.07	1.88	5.37	2.15	2.28	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	18.16	9.91	1.42	4.01	0.94	1.65	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.61	8.53	1.79	4.56	0.99	0.99	2.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.66	9.35	1.64	6.55	1.17	1.64	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	23.43	10.58	1.24	4.15	0.83	0.83	0.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	30.31	9.73	1.77	4.87	2.21	1.11	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.53	8.98	1.25	5.22	1.46	1.46	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	21.53	10.36	1.48	6.46	2.02	1.62	1.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	25.03	10.73	1.19	5.96	1.36	1.36	2.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	23.33	8.68	1.54	7.71	1.93	3.47	2.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	20.29	10.66	0.69	5.16	1.55	1.72	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	28.81	8.23	1.92	8.37	1.10	1.51	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	26.43	9.85	1.81	6.90	1.97	2.13	1.97
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	18.92	5.45	0.68	3.07	1.53	1.36	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	34.18	9.91	2.07	6.66	2.07	2.52	1.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.39	7.20	1.33	2.67	1.87	0.80	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	17.84	10.23	1.94	4.70	2.21	0.97	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	25.00	7.38	0.71	6.43	2.62	3.33	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	21.77	6.45	1.21	5.24	1.41	1.21	1.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	16.39	7.63	0.57	3.58	1.70	2.83	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	20.96	7.69	2.79	5.59	2.10	0.70	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	19.95	9.07	2.42	3.93	1.81	2.42	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	16.52	6.12	0.37	3.55	3.18	2.57	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	22.12	10.48	2.18	6.99	5.39	3.35	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	16.43	9.73	0.61	9.13	2.43	3.65	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.88	6.93	1.81	3.32	3.32	3.01	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	19.90	8.37	1.13	4.52	3.62	3.17	1.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	29.35	10.78	2.10	3.59	5.99	2.70	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	23.85	13.58	1.06	6.14	4.96	5.31	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	11.53	6.62	0.21	3.42	3.84	2.13	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	12.62	4.81	0.00	4.21	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	12.79	11.66	3.57	3.39	0.56	0.19	0.94
Schwann Cells, donor2	11578-120F3	6.80	6.80	6.80	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	17.96	15.12	4.60	3.51	0.88	1.31	1.31
Sebocyte, donor1	11220-116B5	18.08	14.79	8.76	2.19	0.55	0.55	1.10
Sebocyte, donor2	11301-117B5	8.73	17.92	7.81	0.92	0.92	0.00	0.46
Sebocyte, donor3	11378-118B1	12.78	13.60	5.57	4.53	1.86	0.82	1.03
Sertoli Cells, donor1	11255-116F4	31.48	16.57	1.66	9.94	6.63	18.22	1.66
Sertoli Cells, donor2	11333-117F1	19.77	16.95	0.00	5.65	2.82	11.30	2.82
Skeletal Muscle Cells, donor1	11281-116I3	26.31	10.65	4.57	7.21	1.06	1.58	1.58
Skeletal Muscle Cells, donor2	11358-117H8	5.78	6.51	7.95	2.17	0.00	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	21.74	10.87	0.84	7.52	1.67	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	21.84	13.20	2.83	9.90	2.04	3.61	2.36
Skeletal Muscle Cells, donor5	11455-119A6	22.15	11.59	3.12	11.74	1.64	1.34	1.64
Skeletal Muscle Cells, donor6	11459-119B1	26.16	10.93	2.31	11.23	2.00	1.23	1.85
Skeletal Muscle Satellite Cells, donor1	11240-116D7	38.68	14.74	5.67	11.84	2.65	2.52	2.77
Skeletal Muscle Satellite Cells, donor2	11321-117D7	31.82	12.13	4.14	11.13	2.85	2.00	1.85
Skeletal Muscle Satellite Cells, donor3	11397-118D2	28.47	13.49	5.56	5.75	1.39	1.59	2.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	28.73	12.47	6.82	8.09	2.02	2.02	1.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	11.58	15.20	2.17	2.90	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	13.76	11.01	3.85	5.92	2.20	2.75	1.38
Skin - palm, donor1	10286-104F7	13.43	10.74	10.74	0.00	13.43	2.69	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	16.00	12.40	4.18	5.19	1.73	0.72	1.15
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	16.36	11.45	0.00	3.27	0.00	0.82	2.45
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.72	10.00	4.28	3.51	0.26	0.78	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	24.47	20.85	6.95	6.26	2.36	1.67	1.25
Small Airway Epithelial Cells, donor2	11334-117F2	15.89	8.72	1.55	6.05	1.69	3.52	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	9.73	9.52	3.59	1.06	0.85	0.63	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	11.92	13.12	5.85	5.25	1.20	1.57	0.90
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	23.14	12.03	1.23	15.74	9.26	7.10	0.62
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	10.67	3.11	0.44	3.78	1.78	3.11	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	44.67	12.34	5.29	18.81	3.53	1.76	4.11
Smooth Muscle Cells - Aortic, donor1	11283-116I5	18.34	6.41	0.88	7.51	1.33	1.99	2.21
Smooth Muscle Cells - Aortic, donor2	11360-117I1	22.05	12.21	1.97	9.84	2.76	2.76	2.76
Smooth Muscle Cells - Aortic, donor3	11432-118H1	44.81	18.54	3.09	17.77	2.32	6.18	5.41
Smooth Muscle Cells - Bladder, donor1	11519-119H7	17.01	7.01	3.00	6.00	1.00	3.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	28.08	13.17	2.53	8.52	0.80	3.33	2.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	27.93	11.53	3.32	14.19	7.98	8.42	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	27.01	20.74	2.18	12.03	2.30	6.40	2.94
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	32.56	12.70	4.56	7.16	1.63	1.63	3.58
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	23.33	15.95	6.50	6.50	3.25	2.66	1.77
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	22.92	13.24	3.84	8.40	0.71	2.28	1.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	13.34	7.32	3.74	3.74	1.46	0.81	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	9.44	3.96	4.57	4.57	8.83	5.18	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	21.22	10.10	4.80	10.10	3.28	4.29	1.01
Smooth Muscle Cells - Carotid, donor2	11362-117I3	6.12	0.00	6.12	6.12	0.00	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	16.69	8.11	0.48	10.97	2.38	2.86	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	38.49	13.42	5.01	12.83	2.65	2.36	3.69
Smooth Muscle Cells - Colonic, donor2	11320-117D6	28.84	9.90	2.80	9.47	1.94	0.65	2.58
Smooth Muscle Cells - Colonic, donor3	11396-118D1	28.23	11.97	3.25	10.08	2.52	2.31	2.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	24.28	14.08	2.32	8.66	2.01	4.33	3.09
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	21.56	12.93	4.31	20.48	2.16	2.16	6.47
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	29.29	9.26	1.79	17.63	1.79	3.59	1.79
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	15.02	8.53	4.10	5.12	0.34	0.68	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	40.99	14.76	4.16	10.52	2.75	1.10	2.43
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	35.12	17.01	6.34	15.00	7.85	7.04	4.33
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.21	12.06	1.82	13.43	2.28	5.69	2.28
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	27.78	8.45	1.21	16.30	3.62	2.42	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	36.82	21.99	5.03	8.21	1.06	2.91	3.97
Smooth Muscle Cells - Prostate, donor1	11257-116F6	27.03	14.65	2.00	10.12	3.86	4.53	2.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.42	13.90	4.01	11.39	3.51	3.01	2.13
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.08	6.85	5.58	6.34	10.15	3.55	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	34.38	20.66	3.77	17.79	9.95	12.21	3.77
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	18.00	11.25	3.75	11.25	0.75	3.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	15.51	14.21	6.46	11.63	0.00	1.29	3.88
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.23	14.88	8.37	11.16	3.26	1.40	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	28.78	13.63	2.02	13.13	5.05	7.07	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	29.46	14.42	2.82	11.60	2.19	4.39	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	10.03	8.85	1.47	5.01	1.47	1.77	1.47
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	22.41	11.75	3.50	11.16	3.83	5.83	2.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	21.96	4.20	2.80	8.41	5.61	7.01	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	32.81	14.54	1.44	9.93	1.01	2.16	3.74
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	27.79	17.85	4.59	9.18	2.80	2.80	2.80
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	20.87	10.72	1.32	10.15	1.13	2.26	1.32
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	29.77	13.83	3.77	7.27	2.10	2.10	2.10
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.15	13.74	3.94	7.46	1.84	1.76	1.76
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	9.05	1.43	0.00	3.33	0.00	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	29.11	13.95	2.94	11.74	1.71	1.71	4.16
Smooth Muscle Cells - Uterine, donor1	11258-116F7	30.71	16.35	2.87	13.92	3.76	8.40	2.87
Smooth Muscle Cells - Uterine, donor3	11466-119B8	20.48	9.36	1.17	4.39	2.34	3.22	1.46
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	19.63	7.39	2.14	9.13	3.11	2.14	1.55
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	18.25	7.93	1.85	5.82	4.50	3.70	1.59
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	17.85	3.72	1.12	4.84	16.37	10.41	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	30.54	12.22	4.31	8.26	4.31	5.03	1.80
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	28.39	10.22	2.56	13.91	2.27	4.54	3.69
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	26.00	8.67	1.18	10.63	3.15	4.73	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	16.00	6.86	2.03	6.35	5.33	4.57	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	17.17	3.19	2.80	6.39	2.40	1.20	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	19.65	7.94	3.34	7.94	8.78	8.36	1.25
Smooth muscle cells - airway, control, donor4	11969-126D7	19.71	7.33	3.67	7.79	4.58	5.04	1.38
Synoviocyte, donor1	11291-117A4	48.81	16.66	5.39	22.55	6.90	7.57	2.86
Synoviocyte, donor2	11368-117I9	18.61	9.05	5.20	16.26	23.13	13.75	2.01
Synoviocyte, donor3	11440-118H9	16.98	7.60	2.46	11.62	14.97	9.16	0.89
Trabecular Meshwork Cells, donor1	11532-120A2	21.80	17.51	5.00	4.65	1.07	0.71	1.79
Trabecular Meshwork Cells, donor2	11612-122A1	9.91	1.98	1.98	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	14.36	8.80	3.70	2.78	0.69	0.46	1.62
Tracheal Epithelial Cells, donor1	11292-117A5	8.89	18.14	5.02	1.79	0.22	0.36	0.72
Tracheal Epithelial Cells, donor2	11369-118A1	12.76	19.33	6.19	1.93	0.77	0.00	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	9.74	12.60	2.29	1.72	1.15	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	18.45	12.55	3.69	6.77	4.92	3.20	0.37
Urethra, donor2	10319-105A4	8.99	17.98	5.40	5.40	5.40	0.00	1.80
Urothelial Cells, donor1	11520-119H8	11.69	13.55	3.19	3.45	0.27	0.53	0.53
Urothelial Cells, donor2	11600-120H7	4.81	10.82	6.41	0.00	0.80	0.40	0.80
Urothelial Cells, donor3	11681-122H7	3.44	6.65	6.65	0.23	0.23	0.46	0.23
Urothelial cells, donor0	11216-116B1	26.97	20.28	7.80	4.01	0.45	0.45	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	12.46	14.24	21.35	0.89	0.89	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	8.58	35.74	11.44	4.29	2.86	1.43	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.27	7.53	20.54	1.37	0.68	0.68	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	11.36	18.25	21.00	1.72	0.34	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	11.04	10.46	12.20	2.91	1.16	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	13.54	5.21	3.12	3.12	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	9.18	19.27	16.52	3.67	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	6.39	8.22	9.13	0.91	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	33.18	13.94	4.56	4.56	1.36	0.49	2.22
Wilms' tumor cell line:HFWT	10597-108E3	21.12	18.48	1.76	0.88	1.76	1.76	1.76
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	11.45	9.78	6.14	1.12	1.96	0.56	0.84
achilles tendon, donor2	10292-104G4	16.53	10.33	2.07	2.07	6.20	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	11.22	17.59	7.90	0.25	1.02	0.00	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	1.86	11.61	5.80	0.00	0.23	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	5.58	35.73	32.88	0.24	0.71	0.12	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.82	16.33	28.57	0.00	0.54	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	30.64	13.49	3.65	3.09	0.56	0.56	1.97
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	21.15	18.61	16.28	2.33	0.21	0.21	1.06
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.85	12.79	5.44	4.08	0.82	0.54	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	16.74	8.81	5.29	3.53	0.44	0.44	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	14.70	13.07	7.35	1.63	0.41	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	8.15	10.87	7.77	0.78	0.39	0.00	1.94
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	4.78	6.81	2.58	0.37	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	15.60	3.90	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	15.34	9.06	6.27	1.63	0.23	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	16.31	11.65	4.66	1.29	0.26	0.00	0.26
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	9.94	8.18	2.92	0.88	0.58	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	6.97	6.04	5.11	0.46	0.00	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	57.58	13.98	4.52	8.23	0.82	0.00	1.23
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	13.51	7.67	2.46	1.23	0.31	0.00	2.46
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	31.15	12.37	5.97	0.43	0.43	0.43	2.56
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	25.17	11.83	4.85	3.34	0.00	0.00	2.73
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	29.13	16.13	4.81	2.65	0.00	0.48	1.44
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	16.93	8.46	2.00	1.11	0.89	0.00	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	35.36	15.34	2.67	6.67	2.00	2.00	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	7.43	1.86	3.72	1.86	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	11.68	27.50	9.04	1.13	1.51	0.00	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	30.97	8.29	2.62	4.36	0.87	0.87	2.18
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	7.50	11.25	0.00	1.87	0.00	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	20.96	12.01	1.41	3.06	0.71	0.71	1.41
adipose tissue, adult, pool1	10010-101C1	25.13	12.87	6.36	13.34	4.34	3.10	1.24
adipose, donor1	10184-103D4	17.01	19.94	8.21	0.00	0.59	0.00	1.17
adipose, donor2	10185-103D5	21.90	10.14	3.65	2.43	1.62	0.81	0.00
adipose, donor3	10186-103D6	27.77	15.79	4.90	4.36	1.09	1.91	2.72
adipose, donor4	10187-103D7	9.53	6.07	3.47	1.73	1.73	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	18.15	22.57	11.99	0.79	0.32	0.16	2.84
adrenal gland, adult, pool1	10081-102A9	3.64	3.64	3.64	7.28	25.46	14.55	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	13.74	7.20	2.93	1.07	1.33	0.67	0.27
alveolar cell carcinoma cell line:SW 1573	10708-109H6	52.17	15.36	5.00	15.72	2.86	2.50	2.50
amniotic membrane cells, donor1	12235-129G3	33.85	17.85	11.13	4.41	6.49	1.85	2.09
amniotic membrane cells, donor2	12236-129G4	39.90	18.26	8.11	3.04	1.69	1.35	2.37
amniotic membrane cells, donor3	12237-129G5	21.80	32.41	12.67	4.12	4.12	1.18	1.47
amygdala - adult, donor10196	10167-103B5	13.04	24.90	14.23	0.00	1.19	0.00	2.37
amygdala, adult, donor10252	10151-102I7	13.99	15.61	13.79	2.23	0.61	0.81	1.42
amygdala, newborn, donor10223	10360-105E9	11.62	14.52	14.85	2.90	1.94	0.00	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	25.72	21.52	9.30	3.95	1.02	0.51	0.64
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	20.30	8.60	3.53	4.63	0.66	0.66	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	33.07	12.03	5.34	3.34	5.68	1.00	1.67
aorta, adult, pool1	10052-101G7	20.99	7.85	8.43	8.04	6.67	3.53	0.59
appendix, adult	10189-103D9	11.26	13.58	12.42	2.33	2.33	2.33	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	24.08	7.57	1.38	2.75	1.72	0.34	1.72
artery, adult	10190-103E1	16.30	5.43	4.08	13.59	8.15	2.72	1.36
astrocytoma cell line:TM-31	10425-106D2	39.69	18.98	3.33	9.13	1.59	1.74	1.88
b cell line:RPMI1788	10427-106D4	19.33	9.81	3.42	1.04	0.00	0.59	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	46.33	20.53	6.38	19.70	6.38	5.55	2.22
bile duct carcinoma cell line:HuCCT1	10432-106D9	10.52	6.25	0.79	2.88	1.39	1.79	0.50
bile duct carcinoma cell line:TFK-1	10496-107C1	17.24	13.56	2.51	3.85	1.51	1.17	2.01
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	12.30	8.39	3.91	4.47	0.56	0.00	2.24
bladder, adult, pool1	10011-101C2	18.25	11.84	15.75	6.74	6.30	2.28	0.87
blood, adult, pool1	10053-101G8	11.07	13.29	13.29	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	16.27	6.85	0.00	5.99	4.28	1.71	2.57
bone marrow, adult	10192-103E3	33.74	8.77	3.37	14.17	7.42	2.70	2.02
brain, adult, donor1	10084-102B3	15.38	18.45	20.50	3.08	2.05	0.00	0.00
brain, adult, pool1	10012-101C3	18.60	20.82	20.16	1.67	2.90	1.11	1.45
brain, fetal, pool1	10085-102B4	10.69	8.01	34.73	2.67	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	17.51	5.95	2.31	1.65	0.66	0.66	1.98
breast carcinoma cell line:MDA-MB-453	10419-106C5	35.20	19.72	5.24	8.86	5.87	3.12	3.62
breast, adult, donor1	10080-102A8	18.94	10.73	1.89	6.94	3.79	3.16	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	9.02	26.04	8.89	0.76	1.65	0.38	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	27.52	9.28	0.62	4.95	4.95	4.33	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	8.06	9.21	2.99	0.23	1.61	0.00	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	26.39	7.99	3.63	5.08	2.18	1.94	0.48
carcinoid cell line:NCI-H1770	10703-109H1	45.14	24.92	11.28	3.76	0.47	0.00	1.41
carcinoid cell line:NCI-H727	10735-110B6	16.52	12.36	3.39	2.19	0.77	0.33	0.98
carcinoid cell line:SK-PN-DW	10719-109I8	0.95	4.44	2.22	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	34.87	27.68	9.58	5.59	1.86	0.80	1.60
caudate nucleus - adult, donor10196	10177-103C6	9.21	14.97	5.76	3.45	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	10.54	20.58	22.76	4.35	1.84	1.17	0.67
caudate nucleus, adult, donor10258	10379-105H1	7.64	22.16	26.74	3.82	3.82	1.53	0.76
caudate nucleus, newborn, donor10223	10354-105E3	14.28	9.16	13.55	6.23	1.83	0.73	1.10
cerebellum - adult, donor10196	10173-103C2	29.13	11.65	5.83	5.83	0.00	5.83	0.00
cerebellum, adult, donor10252	10166-103B4	29.68	16.44	7.90	6.41	4.91	1.92	1.07
cerebellum, adult, pool1	10083-102B2	31.39	8.97	7.24	5.52	3.10	1.38	1.38
cerebellum, newborn, donor10223	10357-105E6	25.74	13.28	7.47	7.47	7.47	1.66	1.66
cerebral meninges, adult	10188-103D8	17.15	24.71	19.92	2.52	3.53	1.51	2.27
cerebrospinal fluid, donor2	10294-104G6	15.35	5.12	3.65	6.58	1.46	2.19	0.73
cervical cancer cell line:D98-AH2	10552-107I3	34.80	15.10	6.04	10.93	6.90	4.89	1.44
cervical cancer cell line:ME-180	10553-107I4	10.61	58.33	21.21	0.50	0.83	0.50	2.49
cervix, adult, pool1	10013-101C4	18.27	19.00	19.42	6.61	7.87	2.62	1.15
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	29.40	14.21	4.46	8.78	1.95	1.95	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	2.61	0.00	3.92	0.00	1.31	0.00
choriocarcinoma cell line:BeWo	10423-106C9	11.56	4.72	5.22	1.12	0.12	0.12	0.25
choriocarcinoma cell line:SCH	10785-110H2	10.97	12.44	4.93	1.48	0.99	0.25	0.62
choriocarcinoma cell line:T3M-3	10618-108G6	6.88	5.46	0.95	1.19	0.47	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	20.51	10.26	3.42	5.41	3.42	1.71	1.14
chorionic membrane cells, donor2	12239-129G7	34.40	14.91	3.98	9.15	2.68	3.58	2.78
chorionic membrane cells, donor3	12240-129G8	19.78	11.54	4.95	7.14	8.24	3.30	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	23.23	13.13	1.01	2.02	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	23.63	10.37	1.73	2.69	0.58	0.58	1.34
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	19.22	10.98	3.38	4.22	1.06	1.27	1.90
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	18.75	8.99	1.54	1.80	0.00	0.00	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	15.96	8.47	2.18	2.42	0.97	0.48	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	15.07	6.11	2.44	1.22	0.41	0.20	1.43
chronic myelogenous leukemia cell line:K562	10454-106G4	37.40	9.72	1.77	3.24	1.18	0.59	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	10.69	8.86	7.04	1.56	0.26	0.00	0.78
clear cell carcinoma cell line:JHOC-5	10638-108I8	39.54	19.43	7.09	4.34	3.66	0.46	2.97
clear cell carcinoma cell line:TEN	10636-108I6	24.64	10.06	2.26	6.94	1.91	2.08	2.43
colon carcinoma cell line:CACO-2	10513-107D9	42.28	10.80	2.93	7.69	2.20	1.28	1.83
colon carcinoma cell line:COLO-320	10420-106C6	107.56	52.83	22.80	8.74	1.14	0.38	4.56
colon, adult, donor1	10082-102B1	20.23	17.85	11.90	3.57	3.57	0.00	1.19
colon, adult, pool1	10014-101C5	17.16	15.51	10.11	4.23	2.59	2.59	0.94
colon, fetal, donor1	10070-101I7	6.80	7.42	9.27	1.24	1.85	1.85	0.00
common myeloid progenitor CMP, donor1	12130-128D6	45.84	32.08	18.33	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	25.04	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	33.14	15.72	0.85	9.77	1.27	1.27	4.25
cord blood derived cell line:COBL-a 24h infection	10453-106G3	28.68	7.70	1.06	4.23	1.66	1.36	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	34.41	10.43	2.12	6.77	1.27	1.27	2.54
corpus callosum, adult, pool1	10042-101F6	21.01	32.51	13.27	7.30	3.76	2.32	1.66
cruciate ligament, donor2	10295-104G7	13.78	8.92	0.81	4.05	8.10	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	16.85	11.24	9.63	12.04	4.01	4.82	0.00
diencephalon, adult	10193-103E4	14.16	15.60	8.88	1.92	2.64	0.96	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	11.71	18.83	8.27	1.61	1.84	0.23	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	31.29	37.18	7.95	5.39	0.77	1.54	2.82
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	46.94	36.35	4.81	9.87	2.41	2.17	5.78
ductus deferens, adult	10196-103E7	17.44	19.44	7.48	6.98	3.99	1.99	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	11.52	8.64	5.76	2.88	5.76	2.88	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	16.92	11.03	8.09	2.94	5.15	1.47	1.47
dura mater, adult, donor1	10041-101F5	28.24	12.64	10.41	9.33	12.47	6.28	2.31
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	11.55	26.87	5.33	1.33	1.33	2.22	3.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	22.07	38.69	10.32	2.87	0.29	0.57	4.59
embryonic pancreas cell line:1B2C6	10604-108F1	14.80	4.32	0.62	6.17	1.23	0.62	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	23.91	12.71	2.42	3.94	0.30	0.30	0.91
embryonic pancreas cell line:1C3IKEI	10606-108F3	25.32	5.87	1.23	4.63	1.23	0.62	0.93
embryonic pancreas cell line:2C6	10603-108E9	13.13	1.31	0.00	6.57	3.94	5.25	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	10.73	2.68	0.00	0.67	0.00	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	52.56	32.44	12.51	19.03	3.99	5.26	5.98
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	20.74	28.46	7.72	2.89	3.38	0.96	1.29
epidermoid carcinoma cell line:A431	10426-106D3	18.67	22.45	6.34	2.00	1.67	1.22	2.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	22.44	16.06	4.07	5.17	2.75	2.53	0.88
epididymis, adult	10197-103E8	18.42	7.74	6.28	3.98	5.44	1.47	0.84
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	22.35	24.66	15.97	2.84	0.71	0.35	2.31
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	29.89	13.76	1.57	12.19	0.39	0.79	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	17.04	8.78	0.92	4.32	7.34	6.16	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	15.85	8.27	0.79	4.53	6.79	5.12	1.28
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	16.80	9.63	1.23	6.16	5.15	4.59	1.79
esophagus, adult, pool1	10015-101C6	11.57	23.89	11.79	3.93	8.71	3.50	0.96
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	18.53	29.81	13.40	1.88	1.38	0.38	2.76
eye - muscle inferior rectus, donor1	10272-104E2	4.83	4.83	9.66	0.00	7.24	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	12.63	6.31	2.10	6.31	6.31	4.21	2.10
eye - muscle medial, donor2	10299-104H2	16.37	10.42	2.98	2.98	1.49	4.46	0.00
eye - muscle superior, donor2	10297-104G9	9.17	12.61	6.88	2.29	3.44	3.44	0.00
eye - vitreous humor, donor1	10268-104D7	8.74	2.91	1.46	0.00	1.46	1.46	2.91
eye, fetal, donor1	10054-101G9	19.07	17.54	12.46	4.58	3.81	1.27	1.02
fibrosarcoma cell line:HT-1080	10758-110E2	13.85	7.31	3.85	3.08	0.13	0.13	0.77
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	6.89	2.37	2.14	1.19	0.24	0.00	0.95
frontal lobe, adult, pool1	10040-101F4	17.26	32.28	32.46	3.00	3.19	1.50	1.41
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	24.62	18.92	3.30	4.80	1.50	1.80	1.80
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	51.30	14.36	3.84	8.23	0.73	0.55	1.65
gall bladder, adult	10198-103E9	11.59	19.07	10.14	4.83	3.14	0.72	0.72
gamma delta positive T cells, donor1	11937-126A2	6.44	18.25	31.14	1.07	0.54	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	17.18	25.40	24.65	0.00	1.49	0.00	1.12
gastric adenocarcinoma cell line:MKN1	10614-108G2	9.93	9.08	1.06	1.90	3.38	2.53	1.06
gastric adenocarcinoma cell line:MKN45	10612-108F9	20.89	24.76	6.58	2.71	1.35	0.19	0.58
gastric cancer cell line:AZ521	10549-107H9	40.33	21.48	6.39	4.75	0.16	0.82	4.26
gastric cancer cell line:GSS	10560-108A2	10.07	10.07	10.07	0.00	0.92	0.00	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	34.50	16.91	0.23	6.63	2.74	1.37	2.97
giant cell carcinoma cell line:LU65	10487-107B1	5.39	2.87	0.00	3.79	1.84	2.18	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	13.16	16.38	3.92	2.52	1.54	0.70	1.68
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.72	8.23	2.24	5.49	2.00	4.74	0.75
glioblastoma cell line:A172, tech_rep1	10444-106F3	55.41	15.31	4.86	15.52	1.90	3.48	4.33
glioblastoma cell line:A172, tech_rep2	10444-106F3	57.86	14.04	5.20	14.61	1.69	2.95	4.35
glioblastoma cell line:T98G	10485-107A8	39.07	14.68	4.86	5.96	1.32	1.55	2.87
glioma cell line:GI-1	10413-106B8	31.92	8.49	2.64	7.91	2.05	2.93	0.59
globus pallidus - adult, donor10196	10175-103C4	17.49	21.87	9.48	3.64	1.46	0.73	2.19
globus pallidus, adult, donor10252	10161-103A8	16.11	27.09	7.81	4.64	1.22	0.49	1.22
globus pallidus, adult, donor10258	10367-105F7	15.06	15.06	15.06	8.22	6.85	1.37	2.74
globus pallidus, newborn, donor10223	10364-105F4	12.26	11.72	5.33	3.73	2.66	0.53	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	29.37	44.05	29.37	0.00	0.00	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	21.86	21.86	10.93	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	5.23	26.13	5.23	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	23.36	5.76	1.92	8.96	1.28	4.80	1.92
hIPS +CCl2, biol_rep1	14383-156B9	17.91	5.05	0.00	1.84	1.84	0.92	0.00
hIPS +CCl2, biol_rep2	14384-156C1	12.80	5.49	1.83	1.37	0.46	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	10.31	7.73	0.64	1.29	1.93	0.00	0.64
hIPS, biol_rep1	14380-156B6	11.50	5.75	0.00	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	20.58	3.43	0.69	0.69	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	17.66	33.10	8.83	4.41	2.21	0.00	1.10
hairy cell leukemia cell line:Mo	10712-109I1	14.65	11.49	2.87	2.59	0.29	0.57	0.57
heart - mitral valve, adult	10205-103F7	20.33	11.06	4.19	13.75	8.97	6.88	1.20
heart - pulmonic valve, adult	10206-103F8	27.72	7.06	5.75	13.07	6.80	4.45	0.26
heart - tricuspid valve, adult	10207-103F9	11.66	10.82	8.33	3.33	2.50	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	37.14	13.47	2.65	9.79	4.08	3.06	1.43
heart, adult, diseased, donor1	10051-101G6	39.60	14.48	4.68	11.50	5.54	5.11	0.43
heart, adult, pool1	10016-101C7	45.31	14.26	4.60	15.41	0.92	3.45	1.38
heart, fetal, pool1	10046-101G1	44.46	19.51	10.99	14.58	7.19	3.08	2.77
hepatic mesenchymal tumor cell line:LI90	10778-110G4	36.71	10.80	4.94	13.88	2.78	3.09	2.47
hepatoblastoma cell line:HuH-6	10633-108I3	8.32	1.19	1.19	1.19	1.19	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	34.70	11.05	1.33	10.50	7.73	5.75	2.54
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	36.29	12.02	0.85	10.80	9.71	6.92	1.94
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	37.19	11.92	2.02	9.80	9.30	4.24	1.92
hepatoma cell line:Li-7	10484-107A7	18.57	15.46	1.89	6.78	1.78	2.11	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	14.97	9.75	2.71	2.61	0.40	0.60	1.11
hippocampus - adult, donor10196	10169-103B7	16.09	21.77	9.46	0.95	3.79	0.95	0.95
hippocampus, adult, donor10252	10153-102I9	12.25	18.78	13.27	3.67	2.45	1.43	1.43
hippocampus, adult, donor10258	10374-105G5	11.95	21.41	6.97	1.00	2.99	0.00	1.49
hippocampus, newborn, donor10223	10363-105F3	8.46	9.16	10.22	3.17	1.76	0.35	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	15.87	10.38	3.05	1.22	0.61	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	9.03	4.32	1.96	1.57	0.00	0.00	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	9.14	5.08	2.79	2.54	0.51	0.00	0.25
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	9.59	7.33	2.26	1.13	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	4.91	10.84	3.61	0.52	1.03	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	9.49	9.49	5.69	0.38	0.76	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	26.57	19.85	4.67	2.04	1.46	1.17	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	22.19	13.14	6.89	1.94	2.37	0.43	0.65
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	29.20	12.10	2.50	5.84	2.92	0.83	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	37.89	28.18	5.68	6.87	2.37	1.66	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	32.14	22.50	5.79	5.79	2.25	0.96	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	37.70	35.69	3.37	11.45	3.37	1.35	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	4.69	3.44	2.19	1.56	0.16	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	7.37	4.91	0.98	0.98	0.00	0.00	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	20.07	5.24	0.87	1.75	0.87	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	8.02	8.40	3.25	0.19	0.00	0.00	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	12.65	6.98	1.74	0.44	0.44	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	10.00	8.00	5.50	1.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	22.23	10.74	4.90	2.83	1.51	0.19	0.75
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	27.28	13.19	4.55	1.36	2.73	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	20.99	16.60	7.20	2.19	2.51	0.63	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	38.54	19.76	4.41	7.51	3.76	0.65	3.27
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	34.84	22.64	3.19	5.81	3.48	1.74	2.03
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	37.66	19.73	5.98	3.89	2.69	0.90	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	9.05	5.73	1.85	1.29	0.18	0.18	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	6.56	7.13	1.43	2.00	0.29	0.29	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	16.74	10.21	2.04	2.45	0.82	0.41	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	13.73	10.91	3.52	0.70	1.41	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	17.42	12.35	2.85	0.32	0.00	0.00	0.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	16.34	10.59	4.54	1.51	1.21	0.00	1.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	25.86	17.58	3.10	1.55	3.10	1.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	19.26	19.92	3.32	6.64	3.98	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	30.53	15.39	6.93	3.08	2.05	1.03	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	27.61	27.10	5.62	7.41	2.81	2.05	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	44.68	24.99	6.06	3.79	3.79	0.76	3.79
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	41.00	19.83	4.70	7.06	3.36	2.69	3.02
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	9.66	6.52	0.97	1.69	0.97	0.24	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	9.36	7.13	2.67	0.45	2.67	0.89	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	8.78	6.83	0.98	2.44	0.49	0.49	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	11.31	9.47	3.97	1.22	0.31	0.00	1.53
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	16.27	13.01	13.01	0.00	6.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	14.56	10.59	8.27	1.65	0.33	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	22.99	14.78	2.74	1.64	2.19	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	20.27	15.20	5.79	3.26	2.53	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	24.56	12.46	7.12	4.63	2.49	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	34.61	19.09	1.19	1.19	7.16	1.19	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	45.10	37.38	9.21	7.72	1.49	2.17	4.47
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	30.44	22.09	5.93	6.20	1.89	1.89	2.16
immature langerhans cells, donor1	11904-125F5	20.58	7.51	7.26	2.91	0.48	0.00	2.18
immature langerhans cells, donor2	11905-125F6	7.13	6.34	8.71	0.79	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	21.95	35.49	35.01	3.31	1.70	0.95	1.99
keratoacanthoma cell line:HKA-1	10791-110H8	10.08	37.07	22.44	1.30	0.98	0.00	0.98
kidney, adult, pool1	10017-101C8	36.05	19.62	6.41	12.62	4.71	3.80	2.50
kidney, fetal, pool1	10045-101F9	26.60	25.61	14.85	3.96	1.70	1.27	1.91
large cell lung carcinoma cell line:IA-LM	10509-107D5	33.94	15.62	4.12	7.95	1.28	0.57	2.70
large cell lung carcinoma cell line:NCI-H460	10839-111E2	29.45	12.99	1.80	12.58	2.76	3.73	1.38
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	4.59	7.71	2.94	2.94	1.28	0.73	0.37
left atrium, adult, donor1	10079-102A7	22.88	9.81	2.72	5.45	2.72	1.63	0.00
left ventricle, adult, donor1	10078-102A6	22.25	5.56	4.05	12.14	5.56	2.02	0.51
leiomyoblastoma cell line:G-402	10721-110A1	38.58	11.22	3.56	11.49	0.82	1.92	2.19
leiomyoma cell line:10964C	10569-108B2	24.07	12.21	5.39	9.34	3.95	2.51	2.51
leiomyoma cell line:15242A	10570-108B3	19.57	13.59	2.17	14.67	3.80	4.89	2.72
leiomyoma cell line:15425	10571-108B4	28.41	16.75	7.28	12.38	3.64	4.37	2.43
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	25.40	0.00	25.40	0.00	0.00	12.70
lens epithelial cell line:SRA 01/04	10647-109A8	10.46	5.23	1.05	2.09	0.00	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	11.33	15.23	7.44	3.19	0.59	0.47	1.30
liposarcoma cell line:KMLS-1	10782-110G8	43.90	7.19	1.56	11.72	2.19	2.97	2.97
liposarcoma cell line:SW 872	10726-110A6	47.15	12.67	3.17	12.43	2.19	4.02	1.95
liver, adult, pool1	10018-101C9	16.37	6.64	1.46	7.94	5.35	8.10	1.78
liver, fetal, pool1	10086-102B5	8.47	6.58	3.76	8.47	0.94	1.88	0.00
locus coeruleus - adult, donor10196	10182-103D2	14.73	17.50	8.02	3.06	1.17	0.87	1.90
locus coeruleus, adult, donor10252	10165-103B3	13.47	19.19	9.78	2.58	1.48	0.37	0.92
locus coeruleus, adult, donor10258	10375-105G6	13.54	18.34	8.46	4.80	1.97	0.28	2.82
locus coeruleus, newborn, donor10223	10362-105F2	17.25	14.30	5.47	7.57	1.26	1.68	0.84
lung adenocarcinoma cell line:A549	10499-107C4	35.98	15.09	4.01	8.72	0.42	1.66	1.66
lung adenocarcinoma cell line:PC-14	10408-106B3	9.65	1.38	0.69	1.38	2.76	3.45	0.69
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	25.70	12.00	1.98	4.35	0.53	0.92	0.79
lung, adult, pool1	10019-101D1	23.39	16.42	7.21	7.21	7.44	3.90	1.18
lung, fetal, donor1	10068-101I5	17.98	26.26	9.42	3.71	9.42	3.14	0.57
lung, right lower lobe, adult, donor1	10075-102A3	16.04	11.91	4.58	6.87	10.54	6.87	1.37
lymph node, adult, donor1	10077-102A5	12.78	8.99	13.73	5.21	1.89	0.47	0.47
lymphangiectasia cell line:DS-1	10727-110A7	37.26	12.05	1.75	6.36	0.66	0.44	2.41
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	22.64	17.96	11.02	1.81	1.06	0.75	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	26.33	57.77	17.84	4.25	2.55	1.70	3.40
mature adipocyte, donor1	12231-129F8	57.72	15.98	7.99	20.87	2.66	1.78	2.22
mature adipocyte, donor2	12232-129F9	45.86	12.04	6.64	24.70	4.57	4.15	2.70
mature adipocyte, donor3	12233-129G1	38.64	6.64	3.08	17.31	5.69	2.37	1.66
mature adipocyte, donor4	12234-129G2	43.43	10.00	4.21	22.37	6.32	3.69	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	27.88	16.20	4.53	3.10	0.71	0.71	0.95
medial frontal gyrus - adult, donor10196	10170-103B8	24.82	23.69	16.92	2.26	2.26	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.63	15.63	12.51	2.57	2.76	0.55	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	21.29	26.05	13.66	1.59	3.81	0.95	3.81
medial frontal gyrus, newborn, donor10223	10352-105E1	12.79	22.18	13.22	5.12	3.84	0.85	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	17.38	18.73	19.07	1.69	6.92	0.17	1.18
medial temporal gyrus, adult, donor10252	10156-103A3	11.88	21.65	16.13	3.40	2.55	0.21	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	28.89	7.71	0.00	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	14.35	43.06	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	13.28	20.46	12.56	1.08	1.44	0.36	1.44
medulla oblongata - adult, donor10196	10174-103C3	25.96	20.77	7.79	5.84	4.54	2.60	0.65
medulla oblongata, adult, donor10252	10155-103A2	18.73	21.21	7.43	5.88	4.02	1.55	1.08
medulla oblongata, adult, pool1	10038-101F2	22.20	28.32	15.92	5.22	2.86	1.22	2.29
medulla oblongata, newborn, donor10223	10361-105F1	15.97	16.66	8.68	8.33	3.47	0.69	1.04
medulloblastoma cell line:D283 Med	10838-111E1	1.11	5.54	3.32	0.44	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	32.40	19.93	5.01	8.07	0.98	1.96	3.06
melanoma cell line:COLO 679	10514-107E1	28.46	18.69	4.02	7.19	0.72	1.58	1.44
melanoma cell line:G-361	10465-106H6	26.06	12.76	3.26	3.80	3.26	3.26	1.36
meningioma cell line:HKBMM	10691-109F7	30.57	15.38	1.99	8.14	2.17	1.09	1.99
merkel cell carcinoma cell line:MKL-1	10843-111E6	8.81	29.96	14.10	1.76	2.64	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	2.33	16.59	6.74	0.26	0.00	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	37.74	15.65	2.76	20.25	6.60	7.67	3.68
mesenchymal precursor cell - adipose, donor2	11748-123G2	17.81	10.73	2.18	10.91	3.82	4.73	1.82
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	8.70	1.24	12.42	4.97	4.14	3.31
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	25.85	8.71	0.56	18.54	4.78	6.18	0.98
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	23.69	10.59	1.54	19.83	4.24	5.01	1.35
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	37.48	6.94	3.47	20.13	3.47	9.72	1.39
mesenchymal precursor cell - cardiac, donor1	11752-123G6	13.73	4.98	0.69	10.13	3.26	4.46	0.51
mesenchymal precursor cell - cardiac, donor2	11753-123G7	14.61	6.56	2.53	12.77	5.87	7.48	0.92
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.49	11.80	1.99	12.87	5.70	4.38	1.46
mesenchymal precursor cell - cardiac, donor4	11755-123G9	24.71	12.29	2.70	15.80	4.46	6.89	2.03
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.34	12.09	1.99	14.23	1.71	6.54	2.70
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	16.14	6.26	2.63	6.59	0.66	0.99	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	21.03	14.94	2.91	12.73	1.38	3.46	1.80
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	18.50	8.38	3.14	9.77	4.89	4.89	1.05
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	24.09	14.29	2.45	11.23	3.27	3.47	2.86
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	24.44	10.06	2.16	6.83	0.36	1.80	2.16
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	19.86	8.69	2.48	11.59	2.28	2.38	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	18.92	12.08	2.96	5.02	3.19	3.88	2.74
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	24.75	17.20	2.94	17.20	4.62	9.23	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	20.62	10.01	2.54	10.61	1.34	4.33	1.34
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	26.87	17.77	1.31	15.67	2.71	4.29	1.66
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.30	6.63	2.21	6.26	2.21	1.47	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	22.61	10.59	4.01	6.30	2.29	1.43	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	34.94	14.31	4.21	8.84	3.37	1.68	2.11
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	23.75	9.13	2.28	11.42	7.76	7.31	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	18.93	5.12	1.53	8.44	15.09	5.12	0.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	26.70	11.52	2.88	10.73	8.11	6.81	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	28.04	6.16	2.46	9.55	8.01	8.63	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	17.89	8.24	3.53	10.12	10.83	6.59	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.29	8.80	2.03	11.85	12.52	6.09	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	28.29	7.07	2.36	10.22	11.00	7.47	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	22.71	9.27	4.17	10.19	10.19	4.63	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	48.30	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.21	12.69	4.61	10.38	9.52	8.65	2.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	24.32	7.81	2.23	14.95	9.59	6.25	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	28.12	6.01	3.36	11.54	9.37	4.57	1.20
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	26.40	6.60	1.47	13.93	8.07	12.47	0.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	22.15	6.38	3.69	10.07	5.37	8.39	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	24.15	6.55	2.87	10.23	6.96	6.96	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	30.07	10.31	2.58	15.46	9.88	4.73	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	35.55	2.73	5.47	5.47	10.94	10.94	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	0.00	5.16	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	25.01	9.09	2.60	9.42	5.85	6.17	0.97
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	16.00	16.00	4.36	11.64	17.46	5.82	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	25.05	5.33	3.20	6.40	6.40	3.73	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	18.81	8.18	3.27	5.72	5.72	7.36	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	19.05	10.11	3.50	13.22	5.44	4.66	1.55
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	8.39	10.49	2.10	6.30	4.20	6.30	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	20.86	9.93	0.99	8.94	5.96	4.97	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00	14.30	9.53	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.35	8.30	4.15	7.71	4.15	5.34	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	25.59	10.97	2.44	8.53	9.75	3.66	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	25.34	8.23	2.53	11.40	8.87	7.60	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	21.73	7.93	1.72	6.90	6.21	4.14	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	6.45	0.00	6.45	4.30	0.00	6.45
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	19.96	7.98	0.00	19.96	3.99	15.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	6.89	6.89	10.33	10.33	6.89	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	15.89	7.33	0.41	13.04	6.52	3.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	8.74	11.12	1.59	15.09	3.97	3.97	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.61	7.07	2.95	8.84	4.72	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	16.52	7.48	2.49	7.17	2.49	2.49	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	20.05	9.36	2.67	8.02	4.01	6.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	22.47	9.46	3.55	11.83	1.18	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	28.25	7.70	5.14	15.41	12.84	5.14	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	21.34	8.95	2.07	13.77	5.51	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	28.20	15.34	2.47	8.41	5.94	4.45	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	20.19	13.46	2.24	8.97	5.61	4.49	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	19.08	20.35	3.18	9.54	3.82	5.72	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	20.96	15.72	1.21	8.46	2.01	4.43	1.21
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	28.35	28.35	4.36	6.54	4.36	4.36	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	21.54	12.67	0.00	11.40	1.27	2.53	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	24.28	9.71	1.82	10.32	0.00	5.46	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	45.19	13.56	0.00	13.56	0.00	0.00	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	20.59	8.24	0.82	12.36	3.29	2.47	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	33.53	12.90	3.77	15.68	16.07	6.35	3.37
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	24.01	12.66	3.24	14.28	14.28	6.17	1.30
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	22.41	12.22	5.09	15.28	16.30	8.15	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	7.74	7.74	4.64	2.32	1.55	1.55	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	72.29	29.53	6.61	9.45	0.94	2.13	8.98
mesothelioma cell line:ACC-MESO-4	10494-107B8	52.13	35.68	8.34	12.97	3.94	5.79	9.27
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	4.27	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	22.50	10.28	2.47	7.50	2.47	2.98	2.57
mesothelioma cell line:Mero-25	10850-111F4	40.62	35.86	9.31	7.26	2.04	2.27	3.18
mesothelioma cell line:Mero-41	10851-111F5	34.72	12.22	1.22	8.31	2.69	2.44	0.98
mesothelioma cell line:Mero-48a	10852-111F6	43.62	10.63	2.44	13.95	2.44	2.44	1.11
mesothelioma cell line:Mero-82	10853-111F7	23.13	12.09	1.31	7.62	5.52	2.10	1.31
mesothelioma cell line:Mero-83	10854-111F8	25.87	9.70	1.87	8.85	2.21	2.21	1.53
mesothelioma cell line:Mero-84	10855-111F9	21.49	15.92	4.04	3.54	3.03	1.77	2.02
mesothelioma cell line:Mero-95	10856-111G1	34.16	10.97	3.52	9.94	5.18	2.90	3.52
mesothelioma cell line:NCI-H2052	10847-111F1	29.32	14.25	4.80	13.25	2.82	3.48	1.99
mesothelioma cell line:NCI-H226	10846-111E9	36.02	20.63	2.71	14.84	4.16	3.98	2.90
mesothelioma cell line:NCI-H2452	10848-111F2	30.92	14.18	3.07	10.08	3.07	1.02	1.20
mesothelioma cell line:NCI-H28	10845-111E8	11.20	4.58	3.56	2.80	1.02	0.76	0.76
mesothelioma cell line:No36	10857-111G2	24.79	16.64	4.89	7.50	2.28	1.63	1.30
mesothelioma cell line:ONE58	10858-111G3	24.93	6.77	1.63	7.04	1.63	1.63	1.90
migratory langerhans cells, donor1	11901-125F2	22.07	9.98	5.57	3.26	1.54	0.96	0.77
migratory langerhans cells, donor2	11902-125F3	32.48	11.72	6.84	4.03	0.73	0.98	0.98
migratory langerhans cells, donor3	11903-125F4	22.26	13.28	7.00	3.77	1.79	0.54	0.54
mixed mullerian tumor cell line:HTMMT	10689-109F5	31.34	12.41	2.61	7.51	2.61	0.65	2.61
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	21.41	5.30	2.97	7.42	0.42	2.33	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	16.59	14.97	2.76	8.52	0.92	2.30	1.84
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	15.03	10.47	4.76	4.57	0.19	0.95	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	22.36	9.61	2.96	1.48	0.18	0.18	1.11
myeloma cell line:PCM6	10474-106I6	31.03	6.13	0.99	5.53	0.99	2.57	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	16.74	4.57	0.51	5.58	2.54	2.03	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.79	9.41	0.98	11.96	6.86	5.88	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.91	22.73	6.35	2.45	0.56	0.67	0.89
nasal epithelial cells, donor1, tech_rep2	12226-129F3	10.08	19.78	9.41	2.57	0.74	0.44	0.74
nasal epithelial cells, donor2	12227-129F4	8.83	28.70	4.42	2.76	2.76	0.00	2.21
neuroblastoma cell line:CHP-134	10508-107D4	18.63	43.48	22.55	0.23	0.46	0.00	0.92
neuroblastoma cell line:NB-1	10539-107G8	54.07	38.73	14.22	5.05	0.75	0.75	4.12
neuroblastoma cell line:NBsusSR	10607-108F4	3.59	20.25	7.38	0.00	0.21	0.00	0.00
neuroblastoma cell line:NH-12	10555-107I6	8.94	19.01	7.45	0.75	0.75	0.00	0.56
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.47	3.56	5.46	0.00	0.47	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	0.48	6.81	10.61	0.16	0.00	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	5.03	10.26	3.22	0.40	0.81	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	0.64	1.91	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	19.70	6.12	2.93	8.52	2.93	2.13	0.53
neutrophil PMN, donor1	12133-128D9	29.75	44.62	14.87	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	9.47	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	6.43	10.32	8.12	0.68	0.34	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	10.41	28.02	5.60	0.80	0.80	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	36.23	12.18	6.73	10.58	7.05	4.49	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	33.63	12.61	2.63	13.93	4.99	3.42	3.42
nucleus accumbens, adult, pool1	10037-101F1	17.72	31.12	33.93	3.94	2.62	1.50	1.78
occipital cortex - adult, donor10196	10172-103C1	18.54	24.72	24.72	0.00	4.12	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	16.91	18.25	14.22	4.56	1.61	1.07	0.54
occipital cortex, newborn, donor10223	10355-105E4	8.01	15.29	13.10	2.18	1.82	1.09	0.00
occipital lobe, adult, donor1	10076-102A4	8.66	14.69	11.81	0.79	4.46	0.79	0.52
occipital lobe, fetal, donor1	10073-102A1	5.15	24.03	36.90	1.29	2.15	0.86	0.43
occipital pole, adult, pool1	10036-101E9	18.37	34.69	39.03	2.76	1.89	0.87	2.68
olfactory region, adult	10195-103E6	10.70	15.48	13.18	1.34	2.10	1.15	0.19
optic nerve, donor1	10277-104E7	2.00	14.01	8.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	33.49	15.72	2.96	12.99	6.72	5.13	2.62
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	21.71	16.49	4.95	1.10	1.24	0.41	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	3.39	10.33	3.56	0.68	0.68	0.17	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	13.63	7.39	2.08	3.81	3.81	1.62	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	24.99	8.23	2.06	9.99	2.06	3.23	1.47
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	11.21	2.80	0.93	0.93	0.00	0.00	2.80
osteosarcoma cell line:HS-Os-1	10558-107I9	39.23	23.33	7.42	7.00	0.21	0.85	5.09
ovary, adult, pool1	10020-101D2	14.41	17.65	16.51	7.42	15.99	6.55	0.70
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	17.42	8.62	1.65	2.75	0.37	0.37	1.28
pancreas, adult, donor1	10049-101G4	11.29	9.41	4.70	4.70	6.58	6.58	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	14.82	8.11	1.40	0.84	0.00	0.28	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	15.67	12.44	4.94	2.38	1.36	1.02	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	22.52	12.09	3.97	5.13	1.49	1.32	0.66
paracentral gyrus, adult, pool1	10035-101E8	20.96	33.50	33.86	3.29	2.38	1.10	3.20
parietal cortex, adult, donor10258	10373-105G4	8.81	15.41	7.34	0.73	0.73	0.73	1.47
parietal lobe - adult, donor10196	10171-103B9	15.05	29.15	15.05	0.00	2.82	0.00	1.88
parietal lobe, adult, donor10252	10157-103A4	16.82	19.95	12.54	2.85	1.71	0.29	0.86
parietal lobe, adult, pool1	10034-101E7	21.77	31.11	32.25	4.49	2.64	0.53	3.44
parietal lobe, fetal, donor1	10072-101I9	8.73	22.31	25.22	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	13.09	17.20	13.46	2.99	1.50	1.12	1.12
parotid gland, adult	10199-103F1	20.97	9.87	6.17	8.63	4.32	3.70	0.62
penis, adult	10200-103F2	25.78	9.67	5.91	10.21	11.82	1.61	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.19	5.02	7.25	0.00	0.19	0.00	0.37
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	12.38	13.70	6.70	2.04	0.73	0.15	0.73
pineal gland - adult, donor10196	10179-103C8	32.90	16.77	7.10	5.16	2.58	1.29	0.65
pineal gland, adult, donor10252	10160-103A7	71.07	22.50	10.07	11.84	4.15	2.96	2.96
pineal gland, adult, donor10258	10377-105G8	36.37	18.81	6.27	8.15	1.88	1.25	1.25
pituitary gland - adult, donor10196	10180-103C9	77.91	25.30	5.06	12.14	4.05	3.04	3.04
pituitary gland, adult, donor10252	10162-103A9	58.37	28.66	9.38	15.64	1.04	1.56	6.25
pituitary gland, adult, donor10258	10378-105G9	48.52	17.88	8.51	12.77	5.96	3.40	3.40
placenta, adult, pool1	10021-101D3	26.23	10.11	5.16	6.99	3.12	1.40	1.08
plasma cell leukemia cell line:ARH-77	10840-111E3	7.55	10.73	4.50	1.06	0.13	0.26	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	47.00	11.21	2.96	12.14	4.05	3.27	2.80
pons, adult, pool1	10033-101E6	32.36	31.84	16.78	5.16	2.32	1.55	3.96
postcentral gyrus, adult, pool1	10032-101E5	22.84	35.13	32.34	2.96	2.09	0.52	2.70
promyelocytes/myelocytes PMC, donor1	12132-128D8	64.83	12.55	10.46	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	22.03	5.51	0.00	5.51	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	38.02	20.98	5.68	9.91	3.06	1.89	3.79
prostate cancer cell line:PC-3	10439-106E7	40.47	17.42	3.63	9.26	0.73	0.36	3.63
prostate, adult, pool1	10022-101D4	18.86	18.50	12.42	7.89	3.45	2.18	1.00
putamen, adult, donor10196	10176-103C5	7.55	22.66	32.10	2.83	1.89	0.24	0.24
putamen, adult, donor10252	10152-102I8	19.61	27.45	23.53	3.92	1.96	1.96	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	5.46	14.21	12.02	0.00	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	8.70	21.75	23.44	1.21	1.21	1.69	0.48
putamen, newborn, donor10223	10365-105F5	8.25	5.25	1.50	0.75	0.75	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	14.84	4.95	0.58	2.62	2.33	0.58	0.58
rectum, fetal, donor1	10067-101I4	25.04	13.91	15.30	1.39	2.78	0.00	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	107.70	24.80	7.84	20.99	4.88	2.54	5.30
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	31.48	8.28	5.80	7.04	2.49	0.41	1.66
retina, adult, pool1	10030-101E3	37.47	22.76	15.61	7.55	8.75	2.98	2.68
retinoblastoma cell line:Y79	10475-106I7	18.19	12.47	5.46	0.26	0.52	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	39.22	18.93	5.90	5.16	0.61	0.98	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	26.43	16.31	8.15	1.12	0.28	0.00	1.12
sacrococcigeal teratoma cell line:HTST	10695-109G2	15.16	3.03	0.76	10.61	0.76	2.27	0.76
salivary acinar cells, donor1	11771-123I7	8.74	10.04	2.75	2.75	1.29	0.32	0.49
salivary acinar cells, donor2	11772-123I8	7.44	11.98	7.71	2.20	0.96	0.55	0.14
salivary acinar cells, donor3	11773-123I9	0.66	1.32	0.66	1.32	1.99	1.99	1.32
salivary gland, adult, pool1	10093-102C3	20.02	18.30	4.00	9.15	3.43	3.43	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	46.03	13.15	3.63	14.92	0.93	2.28	2.61
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	45.96	15.05	3.41	17.63	0.59	1.65	2.59
seminal vesicle, adult	10201-103F3	15.34	15.87	5.29	5.29	6.88	3.17	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	8.75	16.52	5.59	2.92	1.70	1.21	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	26.17	16.61	7.55	4.28	2.26	0.75	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	29.10	25.09	9.03	5.02	1.00	2.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	25.92	21.89	3.90	7.39	2.96	2.55	2.69
signet ring carcinoma cell line:Kato III	10436-106E4	12.93	11.94	3.65	1.44	0.44	0.88	0.44
signet ring carcinoma cell line:NUGC-4	10483-107A6	27.74	46.58	5.03	6.58	4.00	5.55	4.64
skeletal muscle - soleus muscle, donor1	10282-104F3	7.80	2.84	2.13	7.09	2.13	1.42	0.71
skeletal muscle, adult, pool1	10023-101D5	20.03	6.96	3.84	7.80	2.88	1.80	1.08
skeletal muscle, fetal, donor1	10066-101I3	19.10	5.03	6.03	3.02	4.02	4.02	1.01
skin, adult, donor1	10074-102A2	13.57	0.00	13.57	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	10.73	9.47	15.15	0.63	8.84	1.89	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	15.01	14.68	7.00	3.00	1.33	0.67	2.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	8.51	13.24	1.89	0.63	0.95	0.00	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	4.43	21.01	23.90	0.19	0.96	0.00	0.96
small cell lung carcinoma cell line:LK-2	10541-107H1	5.27	9.72	3.13	0.66	0.33	0.49	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	12.71	4.99	4.50	2.09	0.32	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	36.61	15.04	1.74	12.64	4.14	4.58	1.74
small intestine, adult, pool1	10024-101D6	14.69	14.93	9.32	5.02	7.88	4.66	1.19
small intestine, fetal, donor1	10064-101I1	12.53	13.27	10.32	2.46	3.93	1.72	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	25.65	15.39	1.03	4.10	8.21	2.56	0.00
smooth muscle, adult, pool1	10048-101G3	13.70	13.44	13.18	4.39	7.75	2.33	0.52
somatostatinoma cell line:QGP-1	10781-110G7	17.15	7.77	0.80	5.90	1.07	1.61	1.34
spinal cord - adult, donor10196	10181-103D1	14.68	17.66	6.65	2.98	3.21	1.38	1.38
spinal cord, adult, donor10252	10159-103A6	18.14	25.23	8.28	6.70	1.58	0.79	0.00
spinal cord, adult, donor10258	10369-105F9	8.99	16.60	6.92	4.15	4.15	1.38	0.00
spinal cord, fetal, donor1	10056-101H2	18.30	23.17	17.08	1.83	9.15	3.66	2.44
spinal cord, newborn, donor10223	10359-105E8	23.42	20.21	5.97	6.43	3.21	1.84	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.34	7.77	3.58	12.55	3.73	4.48	1.34
spleen, adult, pool1	10025-101D7	17.73	9.80	6.83	4.19	23.13	14.10	0.66
spleen, fetal, pool1	10044-101F8	15.57	13.98	10.96	4.37	19.23	9.85	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	7.14	9.21	3.73	0.83	0.41	0.00	0.72
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	27.91	24.11	8.92	4.18	1.33	1.14	1.90
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	32.50	11.88	1.05	4.54	2.45	1.75	0.70
squamous cell carcinoma cell line:T3M-5	10616-108G4	23.46	33.62	7.82	9.38	1.17	2.35	2.74
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	47.05	29.83	7.65	15.53	4.73	4.84	3.26
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	18.64	27.11	11.44	0.00	2.12	0.00	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	53.73	24.12	6.77	6.77	0.85	1.27	1.69
stomach, fetal, donor1	10062-101H8	20.29	4.27	1.07	8.54	2.14	6.41	1.07
submaxillary gland, adult	10202-103F4	12.53	9.68	5.13	3.99	4.56	3.42	0.57
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	54.27	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	11.01	20.15	5.19	4.15	2.08	0.83	0.42
substantia nigra, adult, donor10258	10371-105G2	20.69	19.66	8.79	4.66	3.10	0.52	1.55
substantia nigra, newborn, donor10223	10358-105E7	14.13	21.90	0.71	3.53	1.41	1.41	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	20.63	39.89	27.28	0.69	1.15	0.23	2.52
temporal lobe, adult, pool1	10031-101E4	19.41	31.87	32.38	3.56	1.70	0.93	1.95
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	4.27	14.25	27.78	0.00	0.71	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	3.08	24.61	18.46	2.64	2.20	0.00	0.00
tenocyte, donor1	11763-123H8	34.56	9.08	2.44	23.39	11.87	10.47	2.79
tenocyte, donor2	11765-123I1	23.65	9.16	2.29	14.88	13.35	16.40	3.05
tenocyte, donor3	11768-123I4	30.02	9.64	2.22	21.87	21.50	15.94	2.59
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	17.85	11.39	3.06	2.89	1.36	1.53	2.72
teratocarcinoma cell line:NCR-G1	10798-110I6	16.96	16.49	3.24	1.70	1.39	0.46	1.39
teratocarcinoma cell line:PA-1	10807-111A6	22.94	8.83	2.79	2.63	0.62	0.46	1.39
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	12.57	7.62	1.90	3.30	1.40	1.65	1.52
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	8.70	13.99	4.16	1.89	3.78	0.76	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	10.47	8.72	0.44	3.71	0.87	1.20	0.65
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	3.26	2.28	1.95	0.00	0.33	0.33	0.33
testis, adult, pool1	10026-101D8	70.44	25.88	16.54	12.67	13.21	4.62	8.16
testis, adult, pool2	10096-102C6	115.03	31.12	15.79	10.37	12.63	6.32	9.47
thalamus - adult, donor10196	10168-103B6	17.66	17.66	7.73	4.42	1.10	1.10	1.10
thalamus, adult, donor10252	10154-103A1	12.66	20.47	7.81	3.44	2.03	0.63	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	35.41	20.02	3.08	3.08	1.54	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	15.65	12.85	5.43	3.95	1.15	0.33	0.82
thalamus, newborn, donor10223	10366-105F6	16.11	8.63	5.18	6.33	1.15	1.15	2.88
throat, adult	10209-103G2	11.24	8.74	4.99	5.99	7.74	2.75	0.25
throat, fetal, donor1	10061-101H7	22.55	14.63	9.14	3.66	4.27	0.91	1.22
thymic carcinoma cell line:Ty-82	10803-111A2	1.99	27.82	13.71	0.60	0.60	0.00	0.60
thymus, adult, pool1	10027-101D9	3.98	18.99	49.91	0.60	0.40	0.10	0.00
thymus, fetal, pool1	10043-101F7	6.65	24.31	33.98	1.56	0.52	0.42	0.62
thyroid carcinoma cell line:KHM-5M	10776-110G2	40.42	14.63	2.13	14.89	0.80	2.66	2.53
thyroid carcinoma cell line:TCO-1	10783-110G9	15.51	21.65	7.40	2.37	0.70	1.12	2.51
thyroid, adult, pool1	10028-101E1	21.74	15.30	5.69	8.96	6.53	2.61	1.40
thyroid, fetal, donor1	10060-101H6	21.88	10.81	8.96	6.06	4.75	4.22	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	12.32	0.00	3.08	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	9.77	10.23	8.84	4.88	6.74	3.95	1.16
tongue, fetal, donor1	10059-101H5	13.40	6.70	8.28	7.49	6.70	3.55	0.79
tonsil, adult, pool1	10047-101G2	17.63	24.84	21.34	4.61	6.21	3.21	0.90
trachea, adult, pool1	10029-101E2	19.06	15.13	8.18	5.56	3.93	1.96	0.98
trachea, fetal, donor1	10058-101H4	14.62	14.62	10.00	3.08	4.23	4.23	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	32.24	9.92	3.54	17.36	3.19	2.83	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	11.14	6.89	1.82	2.84	0.91	1.11	0.91
transitional-cell carcinoma cell line:JMSU1	10492-107B6	20.84	8.77	2.51	4.54	0.47	0.47	0.31
tridermal teratoma cell line:HGRT	10694-109G1	3.81	0.00	0.00	1.90	1.90	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	14.56	8.72	3.89	3.30	2.71	2.45	0.76
umbilical cord, fetal, donor1	10057-101H3	31.30	8.35	2.09	6.26	4.17	2.09	2.09
uterus, adult, pool1	10100-102D1	22.18	24.57	14.33	9.04	5.80	3.07	0.85
uterus, fetal, donor1	10055-101H1	20.48	21.50	20.48	1.54	1.54	2.05	1.54
vagina, adult	10204-103F6	6.46	10.99	5.82	6.46	3.23	1.29	0.00
vein, adult	10191-103E2	11.62	10.30	15.34	2.63	5.04	1.10	0.44
xeroderma pigentosum b cell line:XPL 17	10563-108A5	8.81	8.28	4.01	0.80	0.53	0.00	1.34